{"content":"<li class=\"n-box-item date-title\" data-end=\"1553054399\" data-start=\"1552968000\" data-txt=\"Monday, December 23, 2019\">Tuesday, March 19, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3444267\" data-ts=\"1553031763\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPRT\" target=\"_blank\">WPRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444267-westport-fuelminus-7-after-q4-loss-2019-revenue-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Westport Fuel -7% after Q4 loss, 2019 revenue outlook</a></h4><ul><li>Westport Fuel Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems Inc.'>WPRT</a>) <font color=\"red\">-7.3%</font> after-hours after posting a larger than expected <a href=\"https://seekingalpha.com/news/3444203-westport-fuel-systems-misses-revenue\" target=\"_blank\">Q4 loss</a> while guiding FY 2019 revenues at the low end of analyst consensus.</li><li>Q4 revenues rose 5% Y/Y to $60.5M, driven by increased aftermarket revenue and shipments of Westport HPDI 2.0, but consolidated gross margin fell to 20% of sales from 24% in the year-ago quarter, due to product mix and higher fixed costs.</li><li>WPRT also forecasts FY 2019 revenues of $265M-$295M vs. $294M analyst consensus estimate.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444267\" data-linked=\"Westport Fuel -7% after Q4 loss, 2019 revenue outlook\" data-tweet=\"$WPRT - Westport Fuel -7% after Q4 loss, 2019 revenue outlook https://seekingalpha.com/news/3444267-westport-fuelminus-7-after-q4-loss-2019-revenue-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3444267-westport-fuelminus-7-after-q4-loss-2019-revenue-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444266\" data-ts=\"1553031651\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENTA\" target=\"_blank\">ENTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444266-enanta-pharmaceuticalsminus-3_6-on-reported-1_6m-share-secondary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enanta Pharmaceuticals -3.6% on reported 1.6M-share secondary</a></h4><ul>   <li>Enanta Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ENTA' title='Enanta Pharmaceuticals, Inc.'>ENTA</a>) is <font color=\"red\">3.6% lower</font> after hours on a reported 1.6M-share secondary offering.</li>    <li>Those shares are said to be offered at $97 each, Bloomberg reports. The stock closed today at $103.77, implying a 6.5% discount.</li>    <li>The seller is unknown although one holder has at least 1.6M shares: BlackRock, with 2.57M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3444266\" data-linked=\"Enanta Pharmaceuticals -3.6% on reported 1.6M-share secondary\" data-tweet=\"$ENTA - Enanta Pharmaceuticals -3.6% on reported 1.6M-share secondary https://seekingalpha.com/news/3444266-enanta-pharmaceuticalsminus-3_6-on-reported-1_6m-share-secondary?source=tweet\" data-url=\"https://seekingalpha.com/news/3444266-enanta-pharmaceuticalsminus-3_6-on-reported-1_6m-share-secondary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444262\" data-ts=\"1553031207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444262-fdx-fnv-trn-and-scs-among-after-hours-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDX, FNV, TRN and SCS among after hours movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/SMAR' title='Smartsheet Inc.'>SMAR</a> <font color=\"green\">+11.5%</font>. <a href='https://seekingalpha.com/symbol/SCS' title='Steelcase Inc.'>SCS</a> <font color=\"green\">+6.9%</font>. <a href='https://seekingalpha.com/symbol/TRN' title='Trinity Industries, Inc.'>TRN</a> <font color=\"green\">+4.6%</font>. <a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle S.A.'>SUPV</a> <font color=\"green\">+3.8%</font>. <a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a> <font color=\"green\">+2.8%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/LX' title='LexinFintech Holdings Ltd.'>LX</a> <font color=\"red\">-8.1%</font>. <a href='https://seekingalpha.com/symbol/TME' title='Tencent Music Entertainment Group'>TME</a> <font color=\"red\">-7.1%.</font> <a href='https://seekingalpha.com/symbol/AIR' title='AAR Corp.'>AIR</a> <font color=\"red\">-6.6%</font>. <a href='https://seekingalpha.com/symbol/FNV' title='Franco-Nevada Corporation'>FNV</a> <font color=\"red\">-5.9%</font><a href='https://seekingalpha.com/symbol/FDX' title='FedEx Corporation'>FDX</a> <font color=\"red\">-4.7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444262\" data-linked=\"FDX, FNV, TRN and SCS among after hours movers\" data-tweet=\"$SMAR $SCS $TRN - FDX, FNV, TRN and SCS among after hours movers https://seekingalpha.com/news/3444262-fdx-fnv-trn-and-scs-among-after-hours-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3444262-fdx-fnv-trn-and-scs-among-after-hours-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444248\" data-ts=\"1553029134\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IIPR\" target=\"_blank\">IIPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444248-cannabis-sector-reit-up-4-on-bullish-btig-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cannabis sector REIT up 4% on bullish BTIG call</a></h4><ul><li>Cannabis REIT Innovative Industrial Properties (NYSE:<a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties, Inc.'>IIPR</a>) was up <font color=\"green\">4%</font> on almost double normal volume in the regular session. BTIG Research raised its fair value target to a Street-high $101 (12% upside) citing increasing investor acceptance of the sector, ample funding sources and management horsepower.</li><li>Analyst Thomas Catherwood expects the REIT to do $140M in acquisitions this year and $160M in 2020 after completing a convertible bond offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444248\" data-linked=\"Cannabis sector REIT up 4% on bullish BTIG call\" data-tweet=\"$IIPR - Cannabis sector REIT up 4% on bullish BTIG call https://seekingalpha.com/news/3444248-cannabis-sector-reit-up-4-on-bullish-btig-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3444248-cannabis-sector-reit-up-4-on-bullish-btig-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444247\" data-ts=\"1553029083\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INVH\" target=\"_blank\">INVH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444247-invitation-homes-backers-selling-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Invitation Homes backers selling shares</a></h4><ul><li>Shareholders affiliated with Blackstone and Starwood Capital are offering 43M shares of Invitation Homes (NYSE:<a href='https://seekingalpha.com/symbol/INVH' title='Invitation Homes Inc.'>INVH</a>). The company itself will receive no proceeds from the sale.</li><li>Shares are <font color=\"red\">down 0.75%</font> after hours.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17449293-invitation-homes-announces-secondary-offering-43000-000-shares-common-stock\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3444247\" data-linked=\"Invitation Homes backers selling shares\" data-tweet=\"$INVH - Invitation Homes backers selling shares https://seekingalpha.com/news/3444247-invitation-homes-backers-selling-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3444247-invitation-homes-backers-selling-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444246\" data-ts=\"1553029035\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444246-viacom-warns-of-directv-blackout-contract-nears-end\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viacom warns of DirecTV blackout as contract nears end</a></h4><ul>   <li>Viacom (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a>) is warning viewers about the <a href=\"https://deadline.com/2019/03/viacom-warns-customers-of-directv-blackout-chance-ahead-of-friday-deadline-1202578534/\" target=\"_blank\">likely next pay-TV blackout</a>, saying its channels could disappear from DirecTV (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) as soon as this weekend.</li>    <li>The two companies' carriage agreement expires at midnight Friday, and Viacom says it's made a series of offers \"good for consumers and good for AT&amp;T\" but gotten to no deal yet.</li>    <li>And it's alluding to the new AT&amp;T/Time Warner combination as a factor: \u201cUnfortunately, AT&amp;T is abusing its new market position by favoring its own content -- which significantly underperforms Viacom\u2019s -\u2013 to stifle competition.\u201d</li>    <li>After hours: <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color=\"red\">-2.2%</font>; <a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a> <font color=\"green\">+0.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3444246\" data-linked=\"Viacom warns of DirecTV blackout as contract nears end\" data-tweet=\"$VIA $VIAB $T - Viacom warns of DirecTV blackout as contract nears end https://seekingalpha.com/news/3444246-viacom-warns-of-directv-blackout-contract-nears-end?source=tweet\" data-url=\"https://seekingalpha.com/news/3444246-viacom-warns-of-directv-blackout-contract-nears-end\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444242\" data-ts=\"1553028514\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TME\" target=\"_blank\">TME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444242-tencent-musicminus-1_5-after-in-line-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tencent Music -1.5% after in-line Q4</a></h4><ul>   <li>Tencent Music Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/TME' title='Tencent Music Entertainment Group'>TME</a>) has turned lower postmarket, <font color=\"red\">down 1.5%</font>, after turning in in-line results in its Q4 earnings.</li>    <li>In user metrics, paying users seemed to show the growth that mostly bullish analysts were looking for. Overall, mobile monthly active users rose 6.8% for online music (to 644M) and 9.1% for social entertainment (to 228M).</li>    <li>Paying users, though, rose 39.2% in online music (to 27M) and 22.9% in social entertainment (to 10.2M).</li>    <li>That mean ARPPU was 8.6 yuan in online music, down 1.1%, and 126.7 yuan for social entertainment, up 24.3%.</li>    <li>Revenues rose 50.5% to 5.4B yuan (about $785M).</li>    <li>Meanwhile, attributable net loss hit 876M yuan, mainly due to a 1.52B-yuan charge tied to equity issuance to Warner Music and Sony Music. Excluding that, non-IFRS net profit rose to 916M yuan ($133M).</li>    <li>Net cash from operations was 1.93B yuan (about $281M), vs. net used cash of 253M yuan the year prior.</li>    <li>Cash and equivalents came to 17.36B yuan ($2.52B), up sharply from the prior-year 5.17B yuan, mainly due to cash from operations and its issuance of shares including the IPO.</li>    <li><a href=\"https://ir.tencentmusic.com/\" target=\"_blank\">Conference call</a> to come at 8 p.m. ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3444235-tencent-music-entertainment-eps-line-beats-revenue\" target=\"_blank\">Tencent Music Entertainment EPS in-line, beats on revenue</a> (Mar. 19 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17449270-tencent-music-entertainment-group-announces-fourth-quarter-full-year-2018-unaudited-financial\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3444242\" data-linked=\"Tencent Music -1.5% after in-line Q4\" data-tweet=\"$TME - Tencent Music -1.5% after in-line Q4 https://seekingalpha.com/news/3444242-tencent-musicminus-1_5-after-in-line-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3444242-tencent-musicminus-1_5-after-in-line-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444215\" data-ts=\"1553027029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCS\" target=\"_blank\">SCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444215-steelcase-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steelcase beats by $0.03, beats on revenue</a></h4><ul><li>Steelcase (NYSE:<a href='https://seekingalpha.com/symbol/SCS' title='Steelcase Inc.'>SCS</a>): Q4 Non-GAAP EPS of $0.29 <span style=\"color:green\">beats by $0.03</span>; GAAP EPS of $0.19.</li><li>Revenue of $912.4M (+18.1% Y/Y) <font color=\"green\">beats by $41.8M</font>.</li><li>Shares <font color=\"green\">+3.55%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17449250-steelcase-reports-fourth-quarter-fiscal-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3444215\" data-linked=\"Steelcase beats by $0.03, beats on revenue\" data-tweet=\"$SCS - Steelcase beats by $0.03, beats on revenue https://seekingalpha.com/news/3444215-steelcase-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3444215-steelcase-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444214\" data-ts=\"1553026923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UPS\" target=\"_blank\">UPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444214-ups-lower-after-fedex-earnings-disappoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UPS lower after FedEx earnings disappoint</a></h4><ul><li>UPS (NYSE:<a href='https://seekingalpha.com/symbol/UPS' title='United Parcel Service, Inc.'>UPS</a>) <font color=\"red\">dips 1.22%</font> in AH trading after FedEx disappointed with its FQ3 report and full-year guidance.</li><li>The shipper pointed to weaker global trade trends.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3444187-fedex-misses-0_07-misses-revenue\" target=\"_blank\">FedEx misses by $0.07, misses on revenue</a> (March 19)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3444210-fedex-minus-4-percent-weaker-global-trade-trends\" target=\"_blank\">FedEx -4% on weaker global trade trends</a> (March 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3444214\" data-linked=\"UPS lower after FedEx earnings disappoint\" data-tweet=\"$UPS - UPS lower after FedEx earnings disappoint https://seekingalpha.com/news/3444214-ups-lower-after-fedex-earnings-disappoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3444214-ups-lower-after-fedex-earnings-disappoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444211\" data-ts=\"1553026740\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMAR\" target=\"_blank\">SMAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444211-smartsheetplus-7-on-q4-beats-upside-revenue-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smartsheet +7% on Q4 beats, upside revenue outlook</a></h4><ul><li>Smartsheet (NYSE:<a href='https://seekingalpha.com/symbol/SMAR' title='Smartsheet Inc.'>SMAR</a>) <font color=\"green\">gains 6.8%</font> after hours following Q4 beats with 58% Y/Y revenue growth and mixed guidance.</li><li>The Q1 outlook has upside revenue from $54M to $55M (consensus: $52.60M) and EPS from -$0.19 to -$0.18 (consensus: -$0.14).</li><li>The FY20 guidance has revenue from $253M to $257M (consensus: $243.79M) and EPS from -$0.59 to -$0.55 (consensus: -$0.52).</li><li>Earnings call starts at 4:30 PM ET with a webcast <a href=\"https://investors.smartsheet.com/home/default.aspx\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17449218-smartsheet-inc-announces-fourth-quarter-full-fiscal-year-2019-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3444195-smartsheet-beats-0_06-beats-revenue\" target=\"_blank\">Smartsheet beats by $0.06, beats on revenue</a> (March 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3444211\" data-linked=\"Smartsheet +7% on Q4 beats, upside revenue outlook\" data-tweet=\"$SMAR - Smartsheet +7% on Q4 beats, upside revenue outlook https://seekingalpha.com/news/3444211-smartsheetplus-7-on-q4-beats-upside-revenue-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3444211-smartsheetplus-7-on-q4-beats-upside-revenue-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444200\" data-ts=\"1553026269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDXG\" target=\"_blank\">IDXG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444200-interpace-diagnostics-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interpace Diagnostics revenue in-line</a></h4><ul><li>Interpace Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/IDXG' title='Interpace Diagnostics Group, Inc.'>IDXG</a>): Q4 GAAP EPS of -$0.15.</li><li>Revenue of $5.83M (+33.4% Y/Y) in-line.</li><li>Shares <font color=\"green\">+3.13%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17449210-interpace-diagnostics-group-reports-full-year-fourth-quarter-2018-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3444200\" data-linked=\"Interpace Diagnostics revenue in-line\" data-tweet=\"$IDXG - Interpace Diagnostics revenue in-line https://seekingalpha.com/news/3444200-interpace-diagnostics-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3444200-interpace-diagnostics-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444195\" data-ts=\"1553026125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMAR\" target=\"_blank\">SMAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444195-smartsheet-beats-0_06-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smartsheet beats by $0.06, beats on revenue</a></h4><ul><li>Smartsheet (NYSE:<a href='https://seekingalpha.com/symbol/SMAR' title='Smartsheet Inc.'>SMAR</a>): Q4 Non-GAAP EPS of -$0.07 <span style=\"color:green\">beats by $0.06</span>; GAAP EPS of -$0.11.</li><li>Revenue of $52.15M (+58.2% Y/Y) <font color=\"green\">beats by $2.43M</font>.</li><li>Shares <font color=\"green\">+1.29%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17449218-smartsheet-inc-announces-fourth-quarter-full-fiscal-year-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3444195\" data-linked=\"Smartsheet beats by $0.06, beats on revenue\" data-tweet=\"$SMAR - Smartsheet beats by $0.06, beats on revenue https://seekingalpha.com/news/3444195-smartsheet-beats-0_06-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3444195-smartsheet-beats-0_06-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444181\" data-ts=\"1553025045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444181-fda-warns-j-and-j-and-sientra-over-lack-of-valid-post-market-studies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA warns J&amp;J and Sientra over lack of valid post-market studies</a></h4><ul><li>The FDA has issued <a href=\"https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm633890.htm\" target=\"_blank\">warning letters</a> to Johnson &amp; Johnson (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"green\">+0.7%</font>) unit Mentor Worldwide LLC and Sientra (<a href='https://seekingalpha.com/symbol/SIEN' title='Sientra, Inc.'>SIEN</a> <font color=\"red\">-4.6%</font>) over their apparent lack of enthusiasm to conduct valid post-approval studies to assess the long-term safety and risks of their silicon gel-filled breast implants, a requirement of their respective approvals.</li><li>The agency cited Mentor for failing to enroll an adequate number of patients in its study, poor follow-up rates and significant data inconsistencies.</li><li>It cited Sientra for poor follow-up rates in its study.</li><li>A warning letter means that the recipient must take prompt action to address the deficiencies or face more serious regulatory action, including the possible removal of the product(s) from the market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444181\" data-linked=\"FDA warns J&amp;J and Sientra over lack of valid post-market studies\" data-tweet=\"$JNJ $SIEN - FDA warns J&amp;J and Sientra over lack of valid post-market studies https://seekingalpha.com/news/3444181-fda-warns-j-and-j-and-sientra-over-lack-of-valid-post-market-studies?source=tweet\" data-url=\"https://seekingalpha.com/news/3444181-fda-warns-j-and-j-and-sientra-over-lack-of-valid-post-market-studies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444180\" data-ts=\"1553024932\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNP\" target=\"_blank\">UNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444180-union-pacificminus-3-loop-capital-downgrades-on-recent-weather-events\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Union Pacific -3% as Loop Capital downgrades on recent weather events</a></h4><ul><li>Union Pacific (<a href='https://seekingalpha.com/symbol/UNP' title='Union Pacific Corporation'>UNP</a> <font color='red'>-3.3%</font>) slumps after Loop Capital <a href=\"https://www.marketwatch.com/story/union-pacifics-stock-paces-dow-transports-losers-after-loop-capital-downgrades-unluckiest-railroad-2019-03-19\" target=\"_blank\">downgrades</a> shares to Hold from Buy with a $182 price target, trimmed from $193, citing serious concerns about the negative impact of recent weather events on the company's railroad network, including on cost efficiency and growth.</li><li>\"Union Pacific wins the award for the world's unluckiest railroad in our view,\" Loop's Rick Paterson writes. \"We thought last May's Oregon tunnel collapse was a cruel blow, but it was nothing compared to the one-two punch of the polar vortex and the Nebraska flooding that currently has the network reeling.\"</li><li>While the weather events have not hurt the stock, as investors view the effects as short-term in nature, Paterson thinks what has happened is \"going to pose a challenge to cost efficiency, service and growth\" in at least during H1.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444180\" data-linked=\"Union Pacific -3% as Loop Capital downgrades on recent weather events\" data-tweet=\"$UNP - Union Pacific -3% as Loop Capital downgrades on recent weather events https://seekingalpha.com/news/3444180-union-pacificminus-3-loop-capital-downgrades-on-recent-weather-events?source=tweet\" data-url=\"https://seekingalpha.com/news/3444180-union-pacificminus-3-loop-capital-downgrades-on-recent-weather-events\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444177\" data-ts=\"1553024293\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MO\" target=\"_blank\">MO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444177-altria-down-2-after-fdas-difficult-meeting-juul\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altria down 2% after FDA&#39;s &quot;difficult&quot; meeting with Juul</a></h4><ul><li>Altria Groups (<a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a> <font color=\"red\">-2.2%</font>) slips on average volume in apparent response to <a href=\"https://finance.yahoo.com/news/altria-shares-fall-fda-apos-192022724.html?ncid=twitter_yfsocialtw_l1gbd0noiom\" target=\"_blank\">comments </a>by FDA Commissioner Scott Gottlieb, M.D. about the agency's recent meeting with Juul, calling it \"difficult.\"</li><li>Related tickers: British American Tobacco (<a href='https://seekingalpha.com/symbol/BTI' title='British American Tobacco p.l.c.'>BTI</a> <font color=\"red\">-0.4%</font>), Vape Holdings (<a href='https://seekingalpha.com/symbol/VAPE' title='Vape Holdings, Inc.'>OTCPK:VAPE</a> <font color=\"red\">-5.9%</font>), Hop-On (<a href='https://seekingalpha.com/symbol/HPNN' title='Hop-On Inc.'>OTCPK:HPNN</a>), mCIG (<a href='https://seekingalpha.com/symbol/MCIG' title='mCig, Inc.'>OTCPK:MCIG</a> <font color=\"green\">+30.8%</font>), Neutra (<a href='https://seekingalpha.com/symbol/NTRR' title='Neutra Corp.'>OTCQB:NTRR</a> <font color=\"red\">-13.6%</font>), VaporBrands International (<a href='https://seekingalpha.com/symbol/VAPR' title='VaporBrands International, Inc.'>OTCPK:VAPR</a> <font color=\"red\">-3.8%</font>), American Heritage International (<a href='https://seekingalpha.com/symbol/AHII' title='American Heritage International Inc.'>OTC:AHII</a>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3444177\" data-linked=\"Altria down 2% after FDA&#39;s &quot;difficult&quot; meeting with Juul\" data-tweet=\"$MO $BTI $VAPE - Altria down 2% after FDA&#39;s &quot;difficult&quot; meeting with Juul https://seekingalpha.com/news/3444177-altria-down-2-after-fdas-difficult-meeting-juul?source=tweet\" data-url=\"https://seekingalpha.com/news/3444177-altria-down-2-after-fdas-difficult-meeting-juul\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>128&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444174\" data-ts=\"1553023452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444174-brazil-seen-likely-to-pay-petrobras-10b-in-transfer-of-rights-dispute\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brazil seen likely to pay Petrobras $10B in transfer-of-rights dispute</a></h4><ul><li>Brazil's government is close to an agreement to <a href=\"https://www.reuters.com/article/petrobras-auction/brazil-govt-likely-to-pay-10-bln-to-petrobras-in-transfer-of-rights-dispute-report-idUSL1N2160EG\" target=\"_blank\">pay ~$10B</a> to Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petróleo Brasileiro S.A. - Petrobras'>PBR</a> <font color='green'>+1.8%</font>) to settle the transfer-of-rights dispute, although the parties have not yet reached final terms, <em>Valor Economico</em> reports.</li><li>The probable payment is a reduction from a previous proposal of $14B, according to the report.</li><li>Separately, Brazilian independent oil company PetroReconcavo has entered direct talks with PBR to <a href=\"https://www.reuters.com/article/us-petrobras-divestiture/brazils-petroreconcavo-in-talks-for-petrobras-onshore-fields-sources-idUSKCN1R025Q\" target=\"_blank\">buy a cluster of 34 oilfields</a> in northeast Brazil, Reuters reports.</li><li>While much attention is geared toward selling big-ticket items such as its TAG pipeline unit, expected to fetch several billion dollars, PBR also is moving to divest dozens of shallow-water and onshore oil and gas fields.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444174\" data-linked=\"Brazil seen likely to pay Petrobras $10B in transfer-of-rights dispute\" data-tweet=\"$PBR - Brazil seen likely to pay Petrobras $10B in transfer-of-rights dispute https://seekingalpha.com/news/3444174-brazil-seen-likely-to-pay-petrobras-10b-in-transfer-of-rights-dispute?source=tweet\" data-url=\"https://seekingalpha.com/news/3444174-brazil-seen-likely-to-pay-petrobras-10b-in-transfer-of-rights-dispute\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444173\" data-ts=\"1553023327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITRM\" target=\"_blank\">ITRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444173-iterum-therapeutics-up-27-on-expanded-qidp-status-for-sulopenem\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iterum Therapeutics up 27% on expanded QIDP status for sulopenem</a></h4><ul><li>Ultra-thinly traded micro cap Iterum Therapeutics (<a href='https://seekingalpha.com/symbol/ITRM' title='Iterum Therapeutics plc'>ITRM</a> <font color=\"green\">+26.8%</font>) is up on almost a 9x surge in volume, albeit on turnover of only 85K shares, on the heels of its <a href=\"https://seekingalpha.com/pr/17447957-iterum-therapeutics-receives-qidp-oral-iv-sulopenem-four-additional-indications-well-fast\" target=\"_blank\">announcement </a>that the FDA has granted Qualified Infectious Disease Product &#40;QIDP&#41; status for oral and intravenous formulations of sulopenem for four new indications: community-acquired pneumonia, acute bacterial prostatitis, gonococcal urethritis and pelvic inflammatory disease.</li><li>Previously, the agency designated QIDP status for the antibiotic for uncomplicated urinary tract infection, complicated urinary tract infection and complicated intra-abdominal infection. Phase 3 trials are in process for the three indications.</li><li>QIDP provides for accelerated review of the marketing application and an additional five-year period of market exclusivity for the indication, if approved.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444173\" data-linked=\"Iterum Therapeutics up 27% on expanded QIDP status for sulopenem\" data-tweet=\"$ITRM - Iterum Therapeutics up 27% on expanded QIDP status for sulopenem https://seekingalpha.com/news/3444173-iterum-therapeutics-up-27-on-expanded-qidp-status-for-sulopenem?source=tweet\" data-url=\"https://seekingalpha.com/news/3444173-iterum-therapeutics-up-27-on-expanded-qidp-status-for-sulopenem\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444172\" data-ts=\"1553022951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444172-amd-stne-bcor-and-eb-among-notable-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD, STNE, BCOR and EB among notable tech movers</a></h4><ul><li><strong>Gainers: </strong>Blucora (NASDAQ:<a href='https://seekingalpha.com/symbol/BCOR' title='Blucora, Inc.'>BCOR</a>) <font color=\"green\">+19%</font>. StoneCo (NASDAQ:<a href='https://seekingalpha.com/symbol/STNE' title='StoneCo Ltd.'>STNE</a>) <font color=\"green\">+19%</font>. The9 Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/NCTY' title='The9 Limited'>NCTY</a>) <font color=\"green\">+18%</font>. Professional Diversity Network (NASDAQ:<a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network, Inc.'>IPDN</a>) <font color=\"green\">+13%</font>. Advanced Micro Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) <font color=\"green\">+12%</font>.</li> <li><strong>Losers: </strong>B Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/BCOM' title='B Communications Ltd'>BCOM</a>) <font color=\"red\">-18%</font>. Pareteum Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) <font color=\"red\">-12%</font>. VivoPower International PLC (NASDAQ:<a href='https://seekingalpha.com/symbol/VVPR' title='VivoPower International PLC'>VVPR</a>) <font color=\"red\">-8%</font>. Inpixon (NASDAQ:<a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a>) <font color=\"red\">-8%</font>. Eventbrite (NYSE:<a href='https://seekingalpha.com/symbol/EB' title='Eventbrite, Inc.'>EB</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3444172\" data-linked=\"AMD, STNE, BCOR and EB among notable tech movers\" data-tweet=\"$BCOR $STNE $NCTY - AMD, STNE, BCOR and EB among notable tech movers https://seekingalpha.com/news/3444172-amd-stne-bcor-and-eb-among-notable-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3444172-amd-stne-bcor-and-eb-among-notable-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444171\" data-ts=\"1553022581\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444171-inmarsat-jumps-20-plus-on-confirming-nonbinding-private-equity-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inmarsat jumps 20%-plus on confirming nonbinding private-equity offer</a></h4><ul>   <li>Inmarsat is jumping (<a href='https://seekingalpha.com/symbol/IMASY' title='Inmarsat Plc'>OTCPK:IMASY</a> <font color=\"green\">+25.8%</font>, <a href='https://seekingalpha.com/symbol/IMASF' title='Inmarsat Plc'>OTCPK:IMASF</a> <font color=\"green\">+19.7%</font>) after the company confirms it's <a href=\"https://tools.eurolandir.com/tools/Pressreleases/GetPressRelease/?ID=3582249&amp;lang=en-GB&amp;companycode=uk-isat&amp;v=\" target=\"_blank\">received a nonbinding proposal</a> for a takeout offer.</li>    <li>The company says it received the proposal for a possible cash offer of $7.21 per share for all of its share capital, from Apax Partners, Warburg Pincus, and Canada Pension Plan Investment Board. That group said Ontario Teachers Pension Plan Board was also part of its consortium.</li>    <li>By rule that consortium is required to say go/no-go on the potential offer by April 16.</li>    <li><a href='https://seekingalpha.com/symbol/IMASY' title='Inmarsat Plc'>OTCPK:IMASY</a> closed yesterday at $5.59/share.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3444171\" data-linked=\"Inmarsat jumps 20%-plus on confirming nonbinding private-equity offer\" data-tweet=\"$IMASY $IMASF - Inmarsat jumps 20%-plus on confirming nonbinding private-equity offer https://seekingalpha.com/news/3444171-inmarsat-jumps-20-plus-on-confirming-nonbinding-private-equity-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3444171-inmarsat-jumps-20-plus-on-confirming-nonbinding-private-equity-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444170\" data-ts=\"1553022523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444170-san-francisco-officials-look-to-ban-e-cigarettes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">San Francisco officials look to ban e-cigarettes</a></h4><ul><li>Altria (<a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a> <font color='red'>-1.9%</font>) is lower after officials in San Francisco proposed legislation to <a href=\"https://www.sfchronicle.com/business/article/San-Francisco-officials-seek-crackdown-on-13700259.php\" target=\"_blank\">ban</a> the sale of e-cigarettes in the city.</li><li>The proposed bill also seeks to bar companies like Juul (<a href='https://seekingalpha.com/symbol/JUUL' title='JUUL'>JUUL</a>) from occupying property owned by the city.</li><li>\"We don\u2019t want them in our city,\" Supervisor Shamann Walton says of e-cigarette sellers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444170\" data-linked=\"San Francisco officials look to ban e-cigarettes\" data-tweet=\"$MO $JUUL - San Francisco officials look to ban e-cigarettes https://seekingalpha.com/news/3444170-san-francisco-officials-look-to-ban-e-cigarettes?source=tweet\" data-url=\"https://seekingalpha.com/news/3444170-san-francisco-officials-look-to-ban-e-cigarettes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>132&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444159\" data-ts=\"1553018983\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRBT\" target=\"_blank\">IRBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444159-irobotminus-3_6-needham-hits-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IRobot -3.6% as Needham hits sidelines</a></h4><ul><li>IRobot (NASDAQ:<a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a>) <font color=\"red\">drops 3.6%</font> after this morning's Needham downgrade from Buy to Hold citing the current valuation.</li><li>The firm says \"bulls can make the case that 2019 guidance is conservative, we can\u2019t help but believe the market is already pricing in upside to estimates.\"</li><li>With the stock up nearly 70% from a December bottom, Needham says it \"could take a breather.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3444159\" data-linked=\"IRobot -3.6% as Needham hits sidelines\" data-tweet=\"$IRBT - IRobot -3.6% as Needham hits sidelines https://seekingalpha.com/news/3444159-irobotminus-3_6-needham-hits-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3444159-irobotminus-3_6-needham-hits-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444156\" data-ts=\"1553018738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444156-trucking-stocks-rattled-covenant-guidance-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trucking stocks rattled by Covenant guidance drop</a></h4><ul><li>Trucking stocks are lower after Covenant Transportation warned on a \"weak\" truckload freight environment and lowered its Q1 profit outlook dramatically.</li><li>Notable decliners include Knight-Transportation (<a href='https://seekingalpha.com/symbol/KNX' title='Knight-Swift Transportation Holdings Inc.'>KNX</a> <font color='red'>-4%</font>), ArcBest (<a href='https://seekingalpha.com/symbol/ARCB' title='ArcBest Corporation'>ARCB</a> <font color='red'>-2.8%</font>), U.S. XPress Enterprises(<a href='https://seekingalpha.com/symbol/USX' title='U.S. Xpress Enterprises, Inc.'>USX</a> <font color='red'>-3.6%</font>), YRC Worldwide (<a href='https://seekingalpha.com/symbol/YRCW' title='YRC Worldwide Inc.'>YRCW</a> <font color='red'>-4.7%</font>), Schneider National (<a href='https://seekingalpha.com/symbol/SNDR' title='Schneider National, Inc.'>SNDR</a> <font color='red'>-4%</font>), Old Dominion Freight Line (<a href='https://seekingalpha.com/symbol/ODFL' title='Old Dominion Freight Line, Inc.'>ODFL</a> <font color='red'>-2.7%</font>) and Werner Enterprises (<a href='https://seekingalpha.com/symbol/WERN' title='Werner Enterprises, Inc.'>WERN</a> <font color='red'>-4.1%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3444147-covenant-transportation-slides-weak-forecast\" target=\"_blank\">Covenant Transportation slides after weak forecast</a> (March 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3444156\" data-linked=\"Trucking stocks rattled by Covenant guidance drop\" data-tweet=\"$KNX $ARCB $USX - Trucking stocks rattled by Covenant guidance drop https://seekingalpha.com/news/3444156-trucking-stocks-rattled-covenant-guidance-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/3444156-trucking-stocks-rattled-covenant-guidance-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444150\" data-ts=\"1553018330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444150-chaparral-energy-and-ferro-among-energy-materials-gainers-approach-resources-and-emerge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chaparral Energy and Ferro among Energy/Materials gainers; Approach Resources and Emerge Energy Services among losers</a></h4><ul><li><b>Gainers: </b>Chaparral Energy (NYSE:<a href='https://seekingalpha.com/symbol/CHAP' title='Chaparral Energy, Inc.'>CHAP</a>) <font color=\"green\">+19%</font>. Ferro (NYSE:<a href='https://seekingalpha.com/symbol/FOE' title='Ferro Corporation'>FOE</a>) <font color=\"green\">+11%</font>. Ferrellgas Partners (NYSE:<a href='https://seekingalpha.com/symbol/FGP' title='Ferrellgas Partners, L.P.'>FGP</a>) <font color=\"green\">+10%</font>. PermRock Royalty Trust (NYSE:<a href='https://seekingalpha.com/symbol/PRT' title='PermRock Royalty Trust'>PRT</a>) <font color=\"green\">+10%</font>. Sibanye Gold (NYSE:<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>Approach Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/AREX' title='Approach Resources, Inc.'>AREX</a>) <font color=\"red\">-29%</font>. Emerge Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/EMES' title='Emerge Energy Services LP'>EMES</a>) <font color=\"red\">-11%</font>. Ring Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/REI' title='Ring Energy, Inc.'>REI</a>) <font color=\"red\">-7%</font>. Smart Sand (NASDAQ:<a href='https://seekingalpha.com/symbol/SND' title='Smart Sand, Inc.'>SND</a>) <font color=\"red\">-7%</font>. PEDEVCO (NYSEMKT:<a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444150\" data-linked=\"Chaparral Energy and Ferro among Energy/Materials gainers; Approach Resources and Emerge Energy Services among losers\" data-tweet=\"$CHAP $FOE $FGP - Chaparral Energy and Ferro among Energy/Materials gainers; Approach Resources and Emerge Energy Services among losers https://seekingalpha.com/news/3444150-chaparral-energy-and-ferro-among-energy-materials-gainers-approach-resources-and-emerge?source=tweet\" data-url=\"https://seekingalpha.com/news/3444150-chaparral-energy-and-ferro-among-energy-materials-gainers-approach-resources-and-emerge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444147\" data-ts=\"1553018114\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVTI\" target=\"_blank\">CVTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444147-covenant-transportation-slides-after-weak-forecast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Covenant Transportation slides after weak forecast</a></h4><ul><li>Covenant Transportation Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CVTI' title='Covenant Transportation Group, Inc.'>CVTI</a>) is <font color=\"red\">down 8.44% </font>after the company guides for Q1 EPS of $0.18 to $0.26 vs. $0.36 consensus.</li><li>Management warned that the truckload freight environment has been weaker this year from late January through mid March.</li><li>Shares of CVTI are below $20 for the first time since January 4.</li><li><a href=\"https://seekingalpha.com/filing/4409696\" target=\"_blank\">SEC Form 8-K</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3444147\" data-linked=\"Covenant Transportation slides after weak forecast\" data-tweet=\"$CVTI - Covenant Transportation slides after weak forecast https://seekingalpha.com/news/3444147-covenant-transportation-slides-after-weak-forecast?source=tweet\" data-url=\"https://seekingalpha.com/news/3444147-covenant-transportation-slides-after-weak-forecast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444132\" data-ts=\"1553014498\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444132-lexinfintech-holdings-leads-financial-gainers-encore-capital-and-leju-holdings-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LexinFintech Holdings leads financial gainers; Encore Capital and Leju Holdings among losers</a></h4><ul><li><b>Gainers:</b> LexinFintech Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/LX' title='LexinFintech Holdings Ltd.'>LX</a>) <font color=\"green\">+8%</font>. Drive Shack (NYSE:<a href='https://seekingalpha.com/symbol/DS' title='Drive Shack Inc.'>DS</a>) <font color=\"green\">+8%</font>. PagSeguro Digital (NYSE:<a href='https://seekingalpha.com/symbol/PAGS' title='PagSeguro Digital Ltd.'>PAGS</a>) <font color=\"green\">+7%</font>. X Financial (NYSE:<a href='https://seekingalpha.com/symbol/XYF' title='X Financial'>XYF</a>) <font color=\"green\">+6%</font>. HFF (NYSE:<a href='https://seekingalpha.com/symbol/HF' title='HFF, Inc.'>HF</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> Oxbridge Re Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/OXBR' title='Oxbridge Re Holdings Limited'>OXBR</a>) <font color=\"red\">-12%</font>. Encore Capital Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ECPG' title='Encore Capital Group, Inc.'>ECPG</a>) <font color=\"red\">-6%</font>. China Internet Nationwide Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a>) <font color=\"red\">-6%</font>. Leju Holdings (NYSE:<a href='https://seekingalpha.com/symbol/LEJU' title='Leju Holdings Limited'>LEJU</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444132\" data-linked=\"LexinFintech Holdings leads financial gainers; Encore Capital and Leju Holdings among losers\" data-tweet=\"$LX $DS $PAGS - LexinFintech Holdings leads financial gainers; Encore Capital and Leju Holdings among losers https://seekingalpha.com/news/3444132-lexinfintech-holdings-leads-financial-gainers-encore-capital-and-leju-holdings-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3444132-lexinfintech-holdings-leads-financial-gainers-encore-capital-and-leju-holdings-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444129\" data-ts=\"1553013828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444129-healthcare-names-dominate-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare names dominate midday movers</a></h4><ul><li><strong>Gainers: </strong>Vaxart (NASDAQ:<a href='https://seekingalpha.com/symbol/VXRT' title='Vaxart, Inc.'>VXRT</a>) <font color=\"green\">+108%</font>. Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) <font color=\"green\">+34%</font>. Conformis (NASDAQ:<a href='https://seekingalpha.com/symbol/CFMS' title='Conformis, Inc.'>CFMS</a>) <font color=\"green\">+23%</font>. Blucora (NASDAQ:<a href='https://seekingalpha.com/symbol/BCOR' title='Blucora, Inc.'>BCOR</a>) <font color=\"green\">+20%</font>. StoneCo (NASDAQ:<a href='https://seekingalpha.com/symbol/STNE' title='StoneCo Ltd.'>STNE</a>) <font color=\"green\">+19%</font>. Realm Therapeutics (<a href='https://seekingalpha.com/symbol/RLM' title='Realm Therapeutics PLC'>RLM</a>) <font color=\"green\">+19%</font>. Iterum Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ITRM' title='Iterum Therapeutics plc'>ITRM</a>) <font color=\"green\">+18%</font>. Altimmune (NASDAQ:<a href='https://seekingalpha.com/symbol/ALT' title='Altimmune, Inc.'>ALT</a>) <font color=\"green\">+18%</font>. Amira Nature Foods (NYSE:<a href='https://seekingalpha.com/symbol/ANFI' title='Amira Nature Foods Ltd.'>ANFI</a>) <font color=\"green\">+17%</font>. NF Energy Saving (NASDAQ:<a href='https://seekingalpha.com/symbol/BIMI' title='NF Energy Saving Corporation'>BIMI</a>) <font color=\"green\">+16%</font>.</li> <li><strong>Losers: </strong>Approach Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/AREX' title='Approach Resources, Inc.'>AREX</a>) <font color=\"red\">-28%</font>. FTD Companies (NASDAQ:<a href='https://seekingalpha.com/symbol/FTD' title='FTD Companies, Inc.'>FTD</a>) <font color=\"red\">-25%</font>. AquaBounty Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AQB' title='AquaBounty Technologies, Inc.'>AQB</a>) <font color=\"red\">-20%</font>. Urovant Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/UROV' title='Urovant Sciences Ltd.'>UROV</a>) <font color=\"red\">-18%</font>. Liquidia Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/LQDA' title='Liquidia Technologies, Inc.'>LQDA</a>) <font color=\"red\">-18%</font>. Selecta Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SELB' title='Selecta Biosciences, Inc.'>SELB</a>) <font color=\"red\">-18%</font>. B Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/BCOM' title='B Communications Ltd'>BCOM</a>) <font color=\"red\">-17%</font>. resTORbio (NASDAQ:<a href='https://seekingalpha.com/symbol/TORC' title='resTORbio, Inc.'>TORC</a>) <font color=\"red\">-16%</font>. NII Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a>) <font color=\"red\">-15%</font>. Orion Group Holdings (NYSE:<a href='https://seekingalpha.com/symbol/ORN' title='Orion Group Holdings, Inc.'>ORN</a>) <font color=\"red\">-14%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3444129\" data-linked=\"Healthcare names dominate midday movers\" data-tweet=\"$VXRT $SRNE $CFMS - Healthcare names dominate midday movers https://seekingalpha.com/news/3444129-healthcare-names-dominate-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3444129-healthcare-names-dominate-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444124\" data-ts=\"1553012580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMCN\" target=\"_blank\">AMCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444124-airmedia-sets-distribution-deal-honeywell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AirMedia sets distribution deal with Honeywell</a></h4><ul>   <li>AirMedia Group (<a href=\"http://seekingalpha.com/symbol/AMCN\" target=\"_blank\">AMCN</a> <font color=\"green\">+5.1%</font>) has a deal to become <a href=\"https://seekingalpha.com/pr/17447815-airmedia-announces-strategic-cooperation-honeywell\" target=\"_blank\">sole distributor</a> of Honeywell's next-gen JetWave satellite communications hardware in China.</li>    <li>The company's subsidiary Air Esurfing is its distributor on the deal, enabling an all-in-one in-flight Wi-Fi service for Chinese airlines.</li>    <li>JetWave enables service through Ka-band links with Inmarsat's Global Xpress Network and satellites ChinaSat 16 and ChinaSat 18.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3444124\" data-linked=\"AirMedia sets distribution deal with Honeywell\" data-tweet=\"$AMCN $ANTE - AirMedia sets distribution deal with Honeywell https://seekingalpha.com/news/3444124-airmedia-sets-distribution-deal-honeywell?source=tweet\" data-url=\"https://seekingalpha.com/news/3444124-airmedia-sets-distribution-deal-honeywell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444280\" data-ts=\"1553012538\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444280-vale-ok-to-re-establish-guaiba-port-terminal-activities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vale OK to re-establish Guaiba port terminal activities</a></h4><ul><li>Vale (<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='green'>+3.1%</font>) says its terminal at Guaiba Island <a href=\"https://www.spglobal.com/platts/en/market-insights/latest-news/metals/031919-brazil-miner-vale-is-allowed-to-reestablish-guaiba-port-terminal-activities\" target=\"_blank\">may resume operations</a> after receiving an injunction allowing it to re-establish activity at the Guaiba Island terminal in Mangaratiba.</li><li>Vale received notice from the Mangaratiba city government a week ago ordering the temporary suspension of port  activities at the terminal, citing irregularities in the iron ore port's  environmental compliance documentation.</li><li>Vale shipped 2.96M metric tons of iron ore from the Guaiba terminal from January to November.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444280\" data-linked=\"Vale OK to re-establish Guaiba port terminal activities\" data-tweet=\"$VALE - Vale OK to re-establish Guaiba port terminal activities https://seekingalpha.com/news/3444280-vale-ok-to-re-establish-guaiba-port-terminal-activities?source=tweet\" data-url=\"https://seekingalpha.com/news/3444280-vale-ok-to-re-establish-guaiba-port-terminal-activities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444122\" data-ts=\"1553012261\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDTI\" target=\"_blank\">IDTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444122-integrated-device-dips-on-cfius-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Integrated Device dips on CFIUS concerns</a></h4><ul><li>Integrated Device (<a href='https://seekingalpha.com/symbol/IDTI' title='Integrated Device Technology, Inc.'>IDTI</a> <font color='red'>-0.1%</font>) dips after dealReporter discusses a potential CFIUS concern with Renesas' acquisition of the company.</li><li>Shareholders worry to dealReporter that the Committee on Foreign Investment in the US could object to Renesas' ties to the China-based Alibaba Cloud. Renesas says the alliance won't pose any \"significant\" risk to the review process and says it has heard any feedback from the committee.</li><li>The CFIUS decision deadline expires on Friday.</li><li>Source: Bloomberg First Word.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444122\" data-linked=\"Integrated Device dips on CFIUS concerns\" data-tweet=\"$IDTI - Integrated Device dips on CFIUS concerns https://seekingalpha.com/news/3444122-integrated-device-dips-on-cfius-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3444122-integrated-device-dips-on-cfius-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444114\" data-ts=\"1553011216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444114-amira-nature-foods-leads-consumer-gainers-energy-focus-and-sequential-brands-in-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amira Nature Foods leads consumer gainers; Energy Focus and Sequential Brands in losers</a></h4><ul><li><b>Gainers: </b>Amira Nature Foods (NYSE:<a href='https://seekingalpha.com/symbol/ANFI' title='Amira Nature Foods Ltd.'>ANFI</a>) <font color=\"green\">+14%</font>. Tredegar (NYSE:<a href='https://seekingalpha.com/symbol/TG' title='Tredegar Corporation'>TG</a>) <font color=\"green\">+7%</font>. Farmmi (NASDAQ:<a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi, Inc.'>FAMI</a>) <font color=\"green\">+6%</font>. Superior Industries International (NYSE:<a href='https://seekingalpha.com/symbol/SUP' title='Superior Industries International, Inc.'>SUP</a>) <font color=\"green\">+6%</font>. Pingtan Marine Enterprise (NASDAQ:<a href='https://seekingalpha.com/symbol/PME' title='Pingtan Marine Enterprise Ltd.'>PME</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Energy Focus (NASDAQ:<a href='https://seekingalpha.com/symbol/EFOI' title='Energy Focus, Inc.'>EFOI</a>) <font color=\"red\">-7%</font>. Sequential Brands Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SQBG' title='Sequential Brands Group, Inc.'>SQBG</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444114\" data-linked=\"Amira Nature Foods leads consumer gainers; Energy Focus and Sequential Brands in losers\" data-tweet=\"$ANFI $TG $FAMI - Amira Nature Foods leads consumer gainers; Energy Focus and Sequential Brands in losers https://seekingalpha.com/news/3444114-amira-nature-foods-leads-consumer-gainers-energy-focus-and-sequential-brands-in-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3444114-amira-nature-foods-leads-consumer-gainers-energy-focus-and-sequential-brands-in-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444113\" data-ts=\"1553010863\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444113-new-fox-debut-paul-ryan-joins-board-shares-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Fox debut: Paul Ryan joins board; shares drop</a></h4><ul>   <li>Transformation day for Fox, as the new Fox Corp. emerges as a stand-alone company hours before Disney closes on its $71B deal for Twenty-First Century Fox's media assets.</li>    <li>New Fox has added former Speaker of the House <a href=\"https://seekingalpha.com/pr/17448396-fox-corporation-announces-first-day-standalone-publicly-traded-company\" target=\"_blank\">Paul Ryan to its board</a>, along with Formula 1 chief (and former Fox insider) Chase Carey; Anne Dias; and Roland Hernandez.</li>    <li>They join a board that already has Jacques Nasser, Rupert Murdoch and Lachlan Murdoch.</li>    <li>Meanwhile new Fox stock -- with the distribution done, it's newly trading under the former 21CF symbols of FOX and FOXA -- is down (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color=\"red\">-3.6%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color=\"red\">-3.7%</font>).</li>    <li>Twenty-First Century Fox <a href=\"https://seekingalpha.com/pr/17448362-21st-century-fox-announces-completion-distribution-connection-disney-acquisition\" target=\"_blank\">distributed to its stockholders</a> a total of 620,501,921 shares of common stock this morning.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3444113\" data-linked=\"New Fox debut: Paul Ryan joins board; shares drop\" data-tweet=\"$FOX $FOXA - New Fox debut: Paul Ryan joins board; shares drop https://seekingalpha.com/news/3444113-new-fox-debut-paul-ryan-joins-board-shares-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/3444113-new-fox-debut-paul-ryan-joins-board-shares-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444110\" data-ts=\"1553010669\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRUB\" target=\"_blank\">GRUB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444110-grubhubminus-6-on-keybanc-user-trend-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GrubHub -6% on KeyBanc user trend warning</a></h4><ul><li>KeyBanc warns of declining GrubHub (NYSE:<a href='https://seekingalpha.com/symbol/GRUB' title='Grubhub Inc.'>GRUB</a>) user trends, citing internal market data.</li><li>Analyst Andy Hargreaves: \"Diner retention, initial diner spend, and peak diner spend all appear to be deteriorating, which suggests lifetime value in newer cohorts is declining.\"</li><li>The analyst says increases in churn and new diner volume suggest GRUB will need to add 3x as many new diners in Q3 as in last year's quarter to maintain Active Diner stability.</li><li>Hargreaves also warns that DoorDash (<a href='https://seekingalpha.com/symbol/DOORD' title='DoorDash'>DOORD</a>) is \"gaining significant share\" in the market.</li><li>GrubHub shares are <font color=\"red\">down 6.2%</font> to $72.28.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444110\" data-linked=\"GrubHub -6% on KeyBanc user trend warning\" data-tweet=\"$GRUB $GRUB $DOORD - GrubHub -6% on KeyBanc user trend warning https://seekingalpha.com/news/3444110-grubhubminus-6-on-keybanc-user-trend-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3444110-grubhubminus-6-on-keybanc-user-trend-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444109\" data-ts=\"1553010662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGL\" target=\"_blank\">SBGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444109-sibanye-stillwaterplus-9-union-fails-to-block-mine-restructuring\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sibanye-Stillwater +9% as union fails to block mine restructuring</a></h4><ul><li>Sibanye-Stillwter (<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a> <font color='green'>+9.4%</font>) wins a go-ahead to <a href=\"https://www.miningmx.com/top-story/36380-amcu-dealt-double-blow-as-fails-to-block-sibanye-stillwater-restructuring/\" target=\"_blank\">continue with the proposed  restructuring</a> of its Driefontein and Beatrix gold mines after South Africa's Labor Court dismisses an interdict attempting to halt the  restructure by the AMCU union.</li><li>AMCU also has <a href=\"http://www.miningweekly.com/article/amcu-reaches-in-principle-settlement-with-ccma-in-wage-dispute-with-sibanye-2019-03-19\" target=\"_blank\">accepted in principle</a> a proposed settlement arbitration agreement  in at attempt to resolve the wage dispute between the union and the miner.</li><li>The union launched a strike at SBGL\u2019s gold operations on Nov. 21.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444109\" data-linked=\"Sibanye-Stillwater +9% as union fails to block mine restructuring\" data-tweet=\"$SBGL - Sibanye-Stillwater +9% as union fails to block mine restructuring https://seekingalpha.com/news/3444109-sibanye-stillwaterplus-9-union-fails-to-block-mine-restructuring?source=tweet\" data-url=\"https://seekingalpha.com/news/3444109-sibanye-stillwaterplus-9-union-fails-to-block-mine-restructuring\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444108\" data-ts=\"1553010425\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRNE\" target=\"_blank\">SRNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444108-sorrento-up-20-ahead-of-corporate-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sorrento up 20% ahead of corporate presentation</a></h4><ul><li>Sorrento Therapeutics (<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color=\"green\">+20.4%</font>) continues its up move on more than double normal volume. Shares have rallied <font color=\"green\">85% </font>since touching $1.80 on March 8.</li><li>The company will deliver a corporate overview tomorrow at Oppenheimer's Healthcare Conference in New York.</li><li>13 months ago, the FDA <a href=\"https://seekingalpha.com/news/3335249-fda-oks-sorrentos-ztlido-phn-related-pain\" target=\"_blank\">approved </a>ZTlido (lidocaine topical system) 1.8% for the relief of pain associated with post-herpetic neuralgia &#40;PHN&#41;, although it only generated $2.6M in sales in 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444108\" data-linked=\"Sorrento up 20% ahead of corporate presentation\" data-tweet=\"$SRNE - Sorrento up 20% ahead of corporate presentation https://seekingalpha.com/news/3444108-sorrento-up-20-ahead-of-corporate-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/3444108-sorrento-up-20-ahead-of-corporate-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444105\" data-ts=\"1553010259\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HDS\" target=\"_blank\">HDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444105-on-hd-supply-q4-results-provides-1q19-and-fy19-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on HD Supply Q4 results; provides 1Q19 and FY19 outlook</a></h4><ul><li>HD Supply (<a href='https://seekingalpha.com/symbol/HDS' title='HD Supply Holdings, Inc.'>HDS</a> <font color=\"red\">-1.2%</font>) reported Q4 net sales growth of 22.2% Y/Y to $1.45B, and organic sales growth of 7.4% Y/Y.</li><li>Facilities Maintenance sales $736M (+14.6% Y/Y), Adj. EBITDA $124M (+21.6% Y/Y); and Adj. EBITDA margin of 16.9% <font color=\"green\">up by 96 bps</font>.</li><li>Construction &amp; Industrial sales $711M (31.2% Y/Y); Adj. EBITDA $63M (+26% Y/Y); and Adj. EBITDA margin of 8.9% <font color=\"red\">down by 36 bps</font>.</li><li>Q4 Gross margin was flat at 39.6%; and operating margin <font color=\"green\">improved by 41 bps</font> to 10.3%.</li><li>Adj. EBITDA increased by 23.03% Y/Y to $187M and margin <font color=\"green\">improved slightly by 8 bps</font> to 12.8%.</li><li>Net cash used in investing activities for the fiscal were $477M, compared to cash provided $2.33B, a year ago.</li><li>During the quarter company repurchased 10.8M shares for $406M at an average price per share of $37.65.</li><li>Preliminary net sales in February for FY19 were ~$423M, representing average daily sales growth of ~8.1% Y/Y.</li><li><strong>1Q19 Outlook:</strong> Net sales $1.46B to $1.52B vs $1.52B consensus; Adj. EBITDA $192M to $207M; and Adj. EPS $0.75 t $0.84 vs $0.84 consensus.</li><li><strong>FY19 Outlook:</strong> Net sales $6.3B to $6.45B vs $6.36B consensus; Adj. EBITDA $900M to $950M; and Adj. EPS $3.52 to $3.81 vs $3.65 consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3443897-hd-supply-holdings-beats-0_03-beats-revenue\" target=\"_blank\">HD Supply Holdings beats by $0.03, beats on revenue</a> (March 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3444105\" data-linked=\"More on HD Supply Q4 results; provides 1Q19 and FY19 outlook\" data-tweet=\"$HDS - More on HD Supply Q4 results; provides 1Q19 and FY19 outlook https://seekingalpha.com/news/3444105-on-hd-supply-q4-results-provides-1q19-and-fy19-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3444105-on-hd-supply-q4-results-provides-1q19-and-fy19-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444104\" data-ts=\"1553009761\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBT\" target=\"_blank\">MBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444104-mobile-telesystemsminus-1_9-amid-light-2019-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mobile TeleSystems -1.9% amid light 2019 guidance</a></h4><ul>   <li>Mobile TeleSystems (NYSE:<a href='https://seekingalpha.com/symbol/MBT' title='Public Joint-Stock Company Mobile TeleSystems'>MBT</a>) is <font color=\"red\">1.9% lower</font> this morning after its Q4 results came in in line with expectations but it guided toward negative OIBDA for the full year.</li>    <li>Revenues rose 11.3% with slightly better small-market growth adding to core Russian revenues that were up 10.7%.</li>    <li>Adjusted OIBDA rose 23%, to 55.6B rubles; of that, Russian OIBDA was up 21.3% to 53B rubles.</li>    <li>And operating profit increased 26.1% to 28.9B rubles.</li>    <li>Mobile subscribers dipped 1.1% Y/Y to 105.3M, however (down 0.2% from the previous quarter). Russian subscribers declined 0.4% Y/Y to 78M; Ukraine subs fell 5.5% to 19.7M; Armenian subs rose 0.4% to 2.1M; and Belarus subs rose 4.5% to 5.5M.</li>    <li>For 2019, it's forecasting revenue growth over 3%, with adjusted OIBDA slightly negative. It sees group capex around 160B rubles.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3444010-mobile-telesystems-pjsc-beats-revenue\" target=\"_blank\">Mobile TeleSystems PJSC beats on revenue</a> (Mar. 19 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17448408-mobile-telesystems-pjsc-q4-and-fy-2018-financial-operating-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3444104\" data-linked=\"Mobile TeleSystems -1.9% amid light 2019 guidance\" data-tweet=\"$MBT - Mobile TeleSystems -1.9% amid light 2019 guidance https://seekingalpha.com/news/3444104-mobile-telesystemsminus-1_9-amid-light-2019-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3444104-mobile-telesystemsminus-1_9-amid-light-2019-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444101\" data-ts=\"1553009605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANFGF\" target=\"_blank\">ANFGF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444101-antofagastaplus-5-full-year-dividend-beats-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Antofagasta +5% as full-year dividend beats expectations</a></h4><ul><li>Antofagasta (<a href='https://seekingalpha.com/symbol/ANFGF' title='Antofagasta plc'>OTC:ANFGF</a> <font color=\"green\">+5.3%</font>) <a href=\"https://www.reuters.com/article/antofagasta-results/update-1-antofagasta-dividend-better-than-expected-profit-in-line-idUSL3N2161R7\" target=\"_blank\">jumps to a seven-month high</a> after announcing a higher than expected dividend for 2018, although full-year revenues fell 0.3% Y/Y to $4.73B and EBITDA slid 14% to $2.23B, hurt by higher input costs and lower sales volumes.</li><li>The Chilean miner reduced its 2018 total dividend by 14% to $0.44/share compared to 2017 but beat the $0.26 expected by analysts.</li><li>Antofagasta previously said annual copper production rose 3% to 725K metric tons and came in at the higher end of its forecast, as its Centinela mine produced better quality ore and higher output.</li><li>CEO Iván Arriagada says the first phase of a planned expansion at its flagship Los Pelambres copper mine has been approved.</li><li>The miner also expects the <a href=\"http://www.mining.com/antofagasta-expects-copper-deficit-300000-tonnes-year/\" target=\"_blank\">global copper deficit to reach 100K-300K metric tons</a> this year as consumption growth remains positive but production increases are minimal.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444101\" data-linked=\"Antofagasta +5% as full-year dividend beats expectations\" data-tweet=\"$ANFGF $ANFGY - Antofagasta +5% as full-year dividend beats expectations https://seekingalpha.com/news/3444101-antofagastaplus-5-full-year-dividend-beats-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3444101-antofagastaplus-5-full-year-dividend-beats-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444100\" data-ts=\"1553009537\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOP\" target=\"_blank\">SHOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444100-shopifyminus-3_5-on-instagrams-checkout-competition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shopify -3.5% on Instagram&#39;s Checkout competition</a></h4><ul><li>RBC Capital Markets thinks Instagram's new Checkout feature could compete with Shopify (NYSE:<a href='https://seekingalpha.com/symbol/SHOP' title='Shopify Inc.'>SHOP</a>) for GPV.</li><li>The firm notes that currently merchants can link their Instagram to their Shopify so that the purchase goes through SHOP's platform, Checkout will circumvent that process and cut out Shopify.</li><li>But RBC still believes in Shopify's platform and channel strategy and reiterates an Outperform rating with a $230 target.</li><li>Shopify shares <font color=\"red\">drop 3.5%</font> to $198.55.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3443993-instagram-adds-app-checkouts\" target=\"_blank\">Instagram adds in-app checkouts</a> (March 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3444100\" data-linked=\"Shopify -3.5% on Instagram&#39;s Checkout competition\" data-tweet=\"$SHOP - Shopify -3.5% on Instagram&#39;s Checkout competition https://seekingalpha.com/news/3444100-shopifyminus-3_5-on-instagrams-checkout-competition?source=tweet\" data-url=\"https://seekingalpha.com/news/3444100-shopifyminus-3_5-on-instagrams-checkout-competition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444091\" data-ts=\"1553007888\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYNA\" target=\"_blank\">SYNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444091-needham-sees-synaptics-earnings-potential-despite-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham sees Synaptics earnings potential despite cut</a></h4><ul><li>Needham reaffirms a Buy rating on Synaptics (NASDAQ:<a href='https://seekingalpha.com/symbol/SYNA' title='Synaptics Incorporated'>SYNA</a>) seeing strong earnings potential despite the recent guidance cut. But the firm trims its PT from the Street-high $60 to $45.</li><li>Analyst Rajvindra Gill notes that the current pullback also comes from the CEO's sudden departure, but says a new CEO could represent a catalyst especially if the leader is focused on growing profitability while open to a potential sale.</li><li>Gill: \"Even with reduced outlook, we see $4+ of earnings and gross margins in 38% range, providing a potential bottom for the shares.\"</li><li>Synaptics shares are <font color=\"green\">up 2.5%</font> to $34.31. SYNA is <font color=\"red\">down 22% </font>on the week.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3443424-synaptics-minus-7-percent-ceo-departure-outlook-cut\" target=\"_blank\">Synaptics -7% on CEO departure, outlook cut</a> (March 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3444091\" data-linked=\"Needham sees Synaptics earnings potential despite cut\" data-tweet=\"$SYNA - Needham sees Synaptics earnings potential despite cut https://seekingalpha.com/news/3444091-needham-sees-synaptics-earnings-potential-despite-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3444091-needham-sees-synaptics-earnings-potential-despite-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444085\" data-ts=\"1553007778\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444085-sorrento-therapeutics-and-altimmune-among-healthcare-gainers-selecta-biosciences-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sorrento Therapeutics and Altimmune among healthcare gainers; Selecta Biosciences  and AquaBounty Technologies among losers</a></h4><ul><li><b>Gainers: </b>Vaxart (NASDAQ:<a href='https://seekingalpha.com/symbol/VXRT' title='Vaxart, Inc.'>VXRT</a>) <font color=\"green\">+153%</font>. Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) <font color=\"green\">+20%</font>. Altimmune (NASDAQ:<a href='https://seekingalpha.com/symbol/ALT' title='Altimmune, Inc.'>ALT</a>) <font color=\"green\">+20%</font>. Aytu BioScience (NASDAQ:<a href='https://seekingalpha.com/symbol/AYTU' title='Aytu BioScience, Inc.'>AYTU</a>) <font color=\"green\">+16%</font>. Conformis (NASDAQ:<a href='https://seekingalpha.com/symbol/CFMS' title='Conformis, Inc.'>CFMS</a>) <font color=\"green\">+16%</font>.</li><li><b>Losers: </b>Urovant Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/UROV' title='Urovant Sciences Ltd.'>UROV</a>) <font color=\"red\">-22%</font>. resTORbio (NASDAQ:<a href='https://seekingalpha.com/symbol/TORC' title='resTORbio, Inc.'>TORC</a>) <font color=\"red\">-20%</font>. AquaBounty Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AQB' title='AquaBounty Technologies, Inc.'>AQB</a>) <font color=\"red\">-19%</font>. Selecta Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SELB' title='Selecta Biosciences, Inc.'>SELB</a>) <font color=\"red\">-16%</font>. PhaseBio Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PHAS' title='PhaseBio Pharmaceuticals, Inc.'>PHAS</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444085\" data-linked=\"Sorrento Therapeutics and Altimmune among healthcare gainers; Selecta Biosciences  and AquaBounty Technologies among losers\" data-tweet=\"$VXRT $SRNE $ALT - Sorrento Therapeutics and Altimmune among healthcare gainers; Selecta Biosciences and AquaBounty Technologies among losers https://seekingalpha.com/news/3444085-sorrento-therapeutics-and-altimmune-among-healthcare-gainers-selecta-biosciences-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3444085-sorrento-therapeutics-and-altimmune-among-healthcare-gainers-selecta-biosciences-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444088\" data-ts=\"1553007773\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLNK\" target=\"_blank\">BLNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444088-blink-charging-finds-partner-in-europe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blink Charging finds a partner in Europe</a></h4><ul> <li>Blink Charging (<a href='https://seekingalpha.com/symbol/BLNK' title='Blink Charging Co.'>BLNK</a> <font color='green'>+4.5%</font>) rallies after signing an agreement with the Eunice Energy Group to establish a joint venture with the purpose of targeting the European EV charging markets.</li><li>The initiative will begin in Greece.</li><li>The range of projects will include the design, development, implementation and operation of renewable energy solutions.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17448711-blink-charging-eunice-energy-group-establish-joint-venture-target-european-electric-vehicle\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3444088\" data-linked=\"Blink Charging finds a partner in Europe\" data-tweet=\"$BLNK - Blink Charging finds a partner in Europe https://seekingalpha.com/news/3444088-blink-charging-finds-partner-in-europe?source=tweet\" data-url=\"https://seekingalpha.com/news/3444088-blink-charging-finds-partner-in-europe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444087\" data-ts=\"1553007754\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BITA\" target=\"_blank\">BITA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444087-bitautominus-2_5-q4-profits-miss-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitauto -2.5% as Q4 profits miss expectations</a></h4><ul>   <li>Bitauto (NYSE:<a href='https://seekingalpha.com/symbol/BITA' title='Bitauto Holdings Limited'>BITA</a>) is <font color=\"red\">off 2.5%</font> after its Q4 profits fell just short of expectations despite 25% gains in revenues that topped company guidance.</li>    <li>Gross profit was up 8.9%, to 1.69B yuan, and operating loss narrowed on a GAAP basis to 325.3M yuan from 645.2M yuan. Non-GAAP operating income rose 184% to 265.4M yuan ($38.6M).</li>    <li>Meanwhile GAAP net loss narrowed to 398.3M yuan ($57.9M), and non-GAAP net income doubled to 199M yuan ($28.9M).</li>    <li>Revenue breakout (using ASC 606): Advertising and subscription, 1.16B yuan (up 15.2%); Transaction services, 1.56B yuan (up 32.5%); Digital marketing solutions, 393.7M yuan (up 29.7%).</li>    <li>For Q1, it's guiding to revenue of 2.47B-2.52B yuan ($359.2M-$366.5M), a 13.8%-16.1% Y/Y gain in renminbi terms.</li>    <li><a href=\"https://seekingalpha.com/pr/17447875-bitauto-announces-fourth-quarter-fiscal-year-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3444087\" data-linked=\"Bitauto -2.5% as Q4 profits miss expectations\" data-tweet=\"$BITA - Bitauto -2.5% as Q4 profits miss expectations https://seekingalpha.com/news/3444087-bitautominus-2_5-q4-profits-miss-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3444087-bitautominus-2_5-q4-profits-miss-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444083\" data-ts=\"1553007429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPMX\" target=\"_blank\">BPMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444083-biopharmx-up-37-after-corporate-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioPharmX up 37% after corporate presentation</a></h4><ul><li>Nano cap BioPharmX (<a href='https://seekingalpha.com/symbol/BPMX' title='BioPharmX Corporation'>BPMX</a> <font color=\"green\">+36.5%</font>) is up on more than a 7x surge in volume on no apparent news.</li><li>Yesterday, the company presented at the ROTH Conference in Southern California. Tomorrow, it will deliver another corporate overview at the Oppenheimer Healthcare Conference in New York.</li><li>Lead candidate is Phase 3-ready BPX-01, a topical minocycline gel, for the treatment of acne vulgaris.</li><li>An upcoming milestone is a <a href=\"https://seekingalpha.com/pr/17444882-biopharmx-reports-fourth-quarter-full-year-2019-financial-results\" target=\"_blank\">data readout</a> in July from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03667222?intr=bpx-04&amp;lead=biopharmx&amp;rank=2\" target=\"_blank\">Phase 2b study</a> of BPX-04, also a topical minocycline gel, in patients with papulopustular rosacea.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444083\" data-linked=\"BioPharmX up 37% after corporate presentation\" data-tweet=\"$BPMX - BioPharmX up 37% after corporate presentation https://seekingalpha.com/news/3444083-biopharmx-up-37-after-corporate-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/3444083-biopharmx-up-37-after-corporate-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444082\" data-ts=\"1553007306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NHYDY\" target=\"_blank\">NHYDY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444082-norsk-hydro-operations-slammed-cyberttack\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Norsk Hydro operations slammed by cyberttack</a></h4><ul><li>Norsk Hydro (<a href='https://seekingalpha.com/symbol/NHYDY' title='Norsk Hydro ASA'>OTCQX:NHYDY</a> <font color='red'>-0.8%</font>) says it has been hit by an \"extensive\" cyberattack that has affected operations at several of its business areas.</li><li>Norsk says it has shut several metal extrusion plants while its giant smelters in countries including Norway, Qatar and Brazil are being operated manually; the attack also affected the company\u2019s IT systems for most of its activities.</li><li>The company says it is working to contain and neutralize the attack but does not yet know the full extent of the situation.</li><li>News of the attack pushed aluminum prices 1.2% higher to a <a href=\"https://www.reuters.com/article/us-norsk-hydro-cyber/aluminum-producer-hydro-hit-by-cyber-attack-idUSKCN1R00NJ\" target=\"_blank\">three-month high</a> of $1,944/mt on the London Metal Exchange before giving up some gains.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444082\" data-linked=\"Norsk Hydro operations slammed by cyberttack\" data-tweet=\"$NHYDY $NHYKF - Norsk Hydro operations slammed by cyberttack https://seekingalpha.com/news/3444082-norsk-hydro-operations-slammed-cyberttack?source=tweet\" data-url=\"https://seekingalpha.com/news/3444082-norsk-hydro-operations-slammed-cyberttack\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444080\" data-ts=\"1553007087\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444080-amdplus-6-on-google-gaming-opportunity-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD +6% on Google gaming opportunity (update)</a></h4><ul><li><strong>Update:</strong> AMD shares head towards Tuesday's close <font color=\"green\">up 11.5% </font>after <a href=\"https://seekingalpha.com/news/3444138-google-announces-game-platform-offering-stadia-updated\" target=\"_blank\">Google confirms</a> the partnership during its Stadia game platform unveiling.</li><li>Morgan Stanley says AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) has a \"significant opportunity\" from cloud gaming chips citing its \"surprise\" success in winning part of Google's (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet Inc.'>GOOG</a> <font color=\"green\">+0.3%</font>)(<a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet Inc.'>GOOGL</a> <font color=\"green\">+0.2%</font>) gaming initiative. Google hosts a keynote at the Game Developers Conference at 1 PM ET today.</li><li>The firm estimates AMD had $50M in cloud-gaming revenue in Q4.</li><li>Analyst Joseph Moore: \"We continue to be impressed by AMD\u2019s progress at using innovative approaches to expand its markets in all segments.\"</li><li>Moore maintains his Underweight rating and $17 PT, seeing the stock as \"ahead of itself\" as cloud gaming won't get AMD back to the Q4 high watermark at any point in 2019.</li><li>AMD shares are <font color=\"green\">up 6.3%</font> to $24.71.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444080\" data-linked=\"AMD +6% on Google gaming opportunity (update)\" data-tweet=\"$AMD $AMD $GOOG - AMD +6% on Google gaming opportunity (update) https://seekingalpha.com/news/3444080-amdplus-6-on-google-gaming-opportunity-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3444080-amdplus-6-on-google-gaming-opportunity-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>312&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444074\" data-ts=\"1553006206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPQ\" target=\"_blank\">HPQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444074-hpplus-1_4-on-new-vr-headset-envy-updates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HP +1.4% on new VR headset, Envy updates</a></h4><ul><li>HP (NYSE:<a href='https://seekingalpha.com/symbol/HPQ' title='HP Inc.'>HPQ</a>) <a href=\"https://seekingalpha.com/pr/17448781-hp-unveils-cutting-edge-virtual-reality-headset-global-partner-conference\" target=\"_blank\">unveils</a> the HP Reverb Virtual Reality Headset, a Windows Mixed Reality headset with 2160 x 2160 resolution optics, a 114-degree field of view, inside-out tracking, and a lighter weight design. There's the Consumer version for $599 and a Pro version for $649, which bundles in a cable for the HP Z VR Backpack and fabric face mask.</li><li>The company also <a href=\"https://seekingalpha.com/pr/17448754-hp-raises-bar-exciting-secure-devices-cutting-edge-pc-innovations\" target=\"_blank\">updates</a> its Envy laptops to include new processors, Alexa integration for some models, and a webcam privacy switch. The new models: the Envy 13 x360 and Envy 15 x360, which both flip into tablets, and the Envy 13 Laptop and Envy 17 Laptop.</li><li>HP shares are <font color=\"green\">up 1.4% </font>to $20.22.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444074\" data-linked=\"HP +1.4% on new VR headset, Envy updates\" data-tweet=\"$HPQ - HP +1.4% on new VR headset, Envy updates https://seekingalpha.com/news/3444074-hpplus-1_4-on-new-vr-headset-envy-updates?source=tweet\" data-url=\"https://seekingalpha.com/news/3444074-hpplus-1_4-on-new-vr-headset-envy-updates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444070\" data-ts=\"1553005703\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUI\" target=\"_blank\">CUI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444070-cui-global-down-9-post-q4-earnings-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CUI Global down 9% post Q4 earnings results</a></h4><ul><li>CUI Global (<a href='https://seekingalpha.com/symbol/CUI' title='CUI Global, Inc.'>CUI</a> <font color=\"red\">-9.9%</font>) reported Q4 revenue growth of 27.5% Y/Y to $26.95M.</li><li>Q4 Gross margin <font color=\"red\">declined by 697 bps</font> to 23.9%; and loss from operations was $7.35M, compared to $6.25M a year ago.</li><li>Adj. EBITDA was negative $2.09M, compared to negative $2.25M a year ago.</li><li>SG&amp;A expenses were $9.39M (+11.3% Y/Y) and as percentage of revenue 34.8% down by 509 bps.</li><li>Net cash used in operating activities for the fiscal was $12.28M, compared to $9.37M a year ago.</li><li>Company has Cash, cash equivalent and restricted cash of $4.5M as of December 31, 2018.</li><li>Power and Electromechanical segment unaudited backlog was $21.8M (+8.9% Y/Y); and Energy segment unaudited backlog was $15.7M (+24.6% Y/Y) at December 31, 2018.</li><li>In Q4 Company announced the sale and leaseback of its corporate headquarters in Tualatin, Oregon. Net proceeds to CUI Global were $4.2M.</li><li>Company secured a $10M line of credit with Bank of America. The new credit facility will replace the  existing U.S.-based revolver facility and UK-based overdraft facility with more favorable terms.</li><li>Company agreed to terms with Virtual Power Systems for an ~20% equity interest in VPS.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3443777-cui-global-beats-revenue\" target=\"_blank\">CUI Global beats on revenue</a> (March 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3444070\" data-linked=\"CUI Global down 9% post Q4 earnings results\" data-tweet=\"$CUI - CUI Global down 9% post Q4 earnings results https://seekingalpha.com/news/3444070-cui-global-down-9-post-q4-earnings-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3444070-cui-global-down-9-post-q4-earnings-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444065\" data-ts=\"1553005121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TORC\" target=\"_blank\">TORC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444065-restorbio-down-20-on-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ResTORbio down 20% on equity offering</a></h4><ul><li>Thinly traded micro cap resTORbio (<a href='https://seekingalpha.com/symbol/TORC' title='resTORbio, Inc.'>TORC</a> <font color=\"red\">-20.3%</font>) is down on more than double normal volume in response to its preliminary <a href=\"https://www.sec.gov/Archives/edgar/data/1720580/000119312519078289/d723059d424b5.htm\" target=\"_blank\">prospectus </a>for $50M stock offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444065\" data-linked=\"ResTORbio down 20% on equity offering\" data-tweet=\"$TORC - ResTORbio down 20% on equity offering https://seekingalpha.com/news/3444065-restorbio-down-20-on-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3444065-restorbio-down-20-on-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444064\" data-ts=\"1553005036\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBEV\" target=\"_blank\">NBEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444064-new-age-beverages-higher-after-guidance-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Age Beverages higher after guidance update</a></h4><ul> <li>New Age Beverages (<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='green'>+1.4%</font>) posts slides ahead of the company's presentation today at the Roth Conference.</li> <li>The company's outlook for 2019 includes a expectations for revenue above $320M, a gross margin rate of over 60% and EBITDA greater than $15M.</li> <li><a href=\"https://seekingalpha.com/filing/4409628\" target=\"_blank\">SEC Form 8-K</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3444064\" data-linked=\"New Age Beverages higher after guidance update\" data-tweet=\"$NBEV - New Age Beverages higher after guidance update https://seekingalpha.com/news/3444064-new-age-beverages-higher-after-guidance-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3444064-new-age-beverages-higher-after-guidance-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444053\" data-ts=\"1553004534\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444053-analyst-takeaways-from-nvidias-conference-keynote\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analyst takeaways from Nvidia&#39;s conference keynote</a></h4><ul><li>Nvidia (<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a> <font color='green'>+3.4%</font>) CEO Jensen Huang gave the keynote address at the GPU Technology Conference late yesterday and analysts found a few notes of interest though the focus remains on today's investor day event.</li><li>Citi's Atif Malik liked the announcement Nvidia will offer cloud gaming in conjunction with SoftBank and LGU+.</li><li>Rosenblatt's Hans Mosesmann says Huang \"purposely stressed the non-hardware related aspects of the Nvidia approach,\" which now includes \"domain specific libraries and that may have competitors reconsider a broad thrust into this market.\"</li><li>Stifel's Kevin Cassidy was \"impressed with the expanding range of GPUs with price/performance/power trade-offs to address markets from supercomputers to toy robots\" and says the company is taking a page from Intel's strategy that \"made the x86 CPU the broadest used CPU architecture.\"</li><li>Reminder: Nvidia's investor day event kicks off at 11:30 AM ET with a webcast available<a href=\"https://investor.nvidia.com/events-and-presentations/events-and-presentations/event-details/2019/NVIDIA-Annual-Investor-Day-2019/default.aspx\" target=\"_blank\"> here</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444053\" data-linked=\"Analyst takeaways from Nvidia&#39;s conference keynote\" data-tweet=\"$NVDA - Analyst takeaways from Nvidia&#39;s conference keynote https://seekingalpha.com/news/3444053-analyst-takeaways-from-nvidias-conference-keynote?source=tweet\" data-url=\"https://seekingalpha.com/news/3444053-analyst-takeaways-from-nvidias-conference-keynote\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444052\" data-ts=\"1553004193\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNST\" target=\"_blank\">MNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444052-monster-beverageminus-4-after-wells-fargo-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monster Beverage -4% after Wells Fargo warning</a></h4><ul> <li>Wells Fargo says new Nielsen data out on Monster Beverage (<a href='https://seekingalpha.com/symbol/MNST' title='Monster Beverage Corporation'>MNST</a> <font color='red'>-4.1%</font>) indicates growth is muted.</li> <li>Analyst Bonnie Herzog notes Monster's sales fell off 3.4% for a a one-week tracking period and was down 1.6% over four weeks amid industry-wide energy drink sales that were higher for both periods.</li> <li>Competition from Bang and the \"efficacy\" of Monster's pricing are cited as potential concerns for shareholders.</li> <li>Wells has a Market Perform rating on Monster and price target of $59.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3444052\" data-linked=\"Monster Beverage -4% after Wells Fargo warning\" data-tweet=\"$MNST - Monster Beverage -4% after Wells Fargo warning https://seekingalpha.com/news/3444052-monster-beverageminus-4-after-wells-fargo-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3444052-monster-beverageminus-4-after-wells-fargo-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444047\" data-ts=\"1553004064\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AYTU\" target=\"_blank\">AYTU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444047-aytu-bio-up-10-on-positive-natesto-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aytu Bio up 10% on positive Natesto data</a></h4><ul><li>Nano cap Aytu BioScience (<a href='https://seekingalpha.com/symbol/AYTU' title='Aytu BioScience, Inc.'>AYTU</a> <font color=\"green\">+9.9%</font>) is up on more than double normal volume on the heels of <a href=\"https://seekingalpha.com/pr/17448259-aytu-bioscience-announces-two-recent-publications-highlighting-improved-efficacy-patient\" target=\"_blank\">published data</a> from an open-label Phase 4 study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03203681?term=Natesto\" target=\"_blank\">MY-T</a>, assessing Natesto in hypogonadal males who were either naïve to testosterone treatment or were previously using topical testosterone. The two manuscripts were published online ahead of the print version in the <em>Canadian Urological Association Journal</em>.</li><li>67.2% of treated men agreed or strongly agreed in their preference of Natesto over topical testosterone gel.</li><li>The MY-T study was supported by Acerus Pharmaceuticals (<a href='https://seekingalpha.com/symbol/TRLPF' title='Acerus Pharmaceuticals Corporation'>OTCPK:TRLPF</a>).</li><li>Natesto is an intranasally administered testosterone replacement therapy.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444047\" data-linked=\"Aytu Bio up 10% on positive Natesto data\" data-tweet=\"$AYTU $TRLPF $AYTU - Aytu Bio up 10% on positive Natesto data https://seekingalpha.com/news/3444047-aytu-bio-up-10-on-positive-natesto-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3444047-aytu-bio-up-10-on-positive-natesto-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444044\" data-ts=\"1553003520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444044-fiat-and-peugeot-higher-on-m-buzz\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fiat and Peugeot higher on M&amp;A buzz</a></h4><ul> <li>Fiat Chrysler Automobiles (<a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles N.V.'>FCAU</a> <font color='green'>+4.5%</font>) jumps higher after Robert Peugeot is reported to have said that the automaker could be a target for Peugeot (<a href='https://seekingalpha.com/symbol/PEUGF' title='Peugeot S.A.'>OTCPK:PEUGF</a>, <a href='https://seekingalpha.com/symbol/PUGOY' title='Peugeot S.A.'>OTCPK:PUGOY</a>) if the planets fall into <a href=\"https://www.reuters.com/article/us-fiatchrysler-m-a-psa/fiat-chrysler-revs-up-as-peugeot-points-to-merger-potential-idUSKCN1R01CS\" target=\"_blank\">alignment</a>.</li><li>Robert Peugeot is president of the family holding company that still has significant control of the French automaker.</li> <li>Over the last year, Fiat and Peugeot have been mentioned often by analysts as strategic M&amp;A partners.</li><li>Peugeot trades 2% higher in Paris off the merger buzz.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3444044\" data-linked=\"Fiat and Peugeot higher on M&amp;A buzz\" data-tweet=\"$FCAU $PEUGF $PUGOY - Fiat and Peugeot higher on M&amp;A buzz https://seekingalpha.com/news/3444044-fiat-and-peugeot-higher-on-m-buzz?source=tweet\" data-url=\"https://seekingalpha.com/news/3444044-fiat-and-peugeot-higher-on-m-buzz\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444043\" data-ts=\"1553003446\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYBR\" target=\"_blank\">CYBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444043-cyberark-gets-buy-start-on-accelerating-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CyberArk gets Buy start on accelerating growth</a></h4><ul><li>FBN Securities initiates CyberArk Software (<a href='https://seekingalpha.com/symbol/CYBR' title='CyberArk Software Ltd.'>CYBR</a> <font color='green'>+0.8%</font>) with an Outperform rating and $130 PT, slightly below the Street-high $133 target.</li><li>The firm cites CYBR's revenue growth that \"accelerated quite notably\" last year and the strong international growth.</li><li>The recent acquisitions of competitors including CA Technologies and BeyondTrust \"created disruption that is accruing to CYBR's advantage.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3444043\" data-linked=\"CyberArk gets Buy start on accelerating growth\" data-tweet=\"$CYBR - CyberArk gets Buy start on accelerating growth https://seekingalpha.com/news/3444043-cyberark-gets-buy-start-on-accelerating-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3444043-cyberark-gets-buy-start-on-accelerating-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444037\" data-ts=\"1553002907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFSW\" target=\"_blank\">PFSW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444037-pfsweb-slides-17-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PFSweb slides 17% post Q4 results</a></h4><ul><li>PFSweb (<a href='https://seekingalpha.com/symbol/PFSW' title='PFSweb, Inc.'>PFSW</a>) reports <a href=\"https://seekingalpha.com/pr/17447517-pfsweb-reports-fourth-quarter-full-year-2018-results\" target=\"_blank\">Q4</a> revenue increased of 0.3% to $92.99M.</li><li>Segment revenue: Service fee revenue $68M (+1.5% Y/Y); Product revenue $7.3M (-25.5% Y/Y) and pass-through $17.8M (+12.7% Y/Y).</li><li>Service fee equivalent revenue was $68.3M (+1% Y/Y), the improvement was driven by stronger client volumes in the company\u2019s PFS segment, partially offset by lower new client project activity in the LiveArea segment.</li><li>Service fee gross margin <font color=\"green\">increased 10 bps</font> to 34.7%.</li><li>Adj. EBITDA margin was <font color=\"red\">declined 36 bps</font> to 9.8%.</li><li>As a percentage of SFE revenue, adj. EBITDA <font color=\"red\">declined 60 bps</font> to 13.3%, was due to increased sales, marketing and infrastructure related expenses to support the company\u2019s targeted growth.</li><li>Net debt decreased 6% Y/Y to $26.5M; cash &amp; equivalents totaled $15.4M (-19.4% Y/Y) whereas, total debt decreased 11.2% Y/Y to $42M.</li><li><b>2019 Outlook:</b> SFE revenue to increase in the low-single digits on a percentage basis Y/Y; adj. EBITDA to increase in the low to mid-single digits on a percentage basis Y/Y.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3443782-pfsweb-misses-0_07-beats-revenue\" target=\"_blank\">PFSweb misses by $0.07, beats on revenue</a> (Mar. 18 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3444037\" data-linked=\"PFSweb slides 17% post Q4 results\" data-tweet=\"$PFSW - PFSweb slides 17% post Q4 results https://seekingalpha.com/news/3444037-pfsweb-slides-17-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3444037-pfsweb-slides-17-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444038\" data-ts=\"1553002697\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARAV\" target=\"_blank\">ARAV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444038-aravive-up-5-on-encouraging-avbminus-500-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aravive up 5% on encouraging AVB-500 data</a></h4><ul><li>Thinly traded nano cap Aravive (<a href='https://seekingalpha.com/symbol/ARAV' title='Aravive, Inc.'>ARAV</a>) is up <font color=\"green\">5%</font> in early trade in response to <a href=\"https://seekingalpha.com/pr/17448002-aravive-announces-retrospective-analysis-showing-increased-gas6-levels-associated\" target=\"_blank\">positive data</a> from a nonclinical ovarian cancer study of lead candidate AVB-500, a GAS6 binding protein, supporting the rationale for its mechanism of action. The results were presented at the GSO Annual Meeting on Women's Cancer in Honolulu.</li><li>Binding to GAS6 turns off a signaling pathway in tumor cells called AXL that plays a key role in cancer cell survival and proliferation.</li><li>Patients with high-grade serous ovarian cancer with high tumor GAS6 expression (&gt;80%) experienced median progression-free survival &#40;PFS&#41; of 7.7 months compared to 15.2 months in patients with low tumor GAS6 expression (&lt;35%).</li><li>Median PFS was 9.9 months in patients with high serum GAS6 levels (&gt;25 ng/mL) compared to 20.4 months in those with low serum levels of GAS6 (&lt;15 mg/mL).</li><li>Data from mouse tumor models showed that the combination of AVB-500 and chemo decreased tumor and stromal cell viability, tumor burden and increased DNA damage.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444038\" data-linked=\"Aravive up 5% on encouraging AVB-500 data\" data-tweet=\"$ARAV - Aravive up 5% on encouraging AVB-500 data https://seekingalpha.com/news/3444038-aravive-up-5-on-encouraging-avbminus-500-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3444038-aravive-up-5-on-encouraging-avbminus-500-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444035\" data-ts=\"1553002683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESLT\" target=\"_blank\">ESLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444035-elbit-sees-imi-making-profit-in-2019\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elbit sees IMI making a profit in 2019</a></h4><ul><li>Elbit Systems (<a href='https://seekingalpha.com/symbol/ESLT' title='Elbit Systems Ltd.'>ESLT</a> <font color=\"red\">-1.2%</font>) <a href=\"https://www.reuters.com/article/elbit-systems-results/update-1-israels-elbit-sees-weapons-unit-imi-making-a-profit-in-2019-idUSL8N21628K\" target=\"_blank\">said</a> costs relating to its acquisition of IMI Systems sent its quarterly profit lower, but it forecast that the weapons and military technology maker will start to make a profit this year.</li><li>In November, Elbit bought IMI from the government for $500M. It said expenses related to the deal reached $69.5M in the quarter.</li><li>The company earned $1.91 per diluted share in the October-December  period, down from $2.01 a year earlier. Revenue rose to $1.08B from  $1.0B.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3443910-elbit-systems-reports-q4-results\" target=\"_blank\">Elbit Systems reports Q4 results</a> (Mar. 19 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3444035\" data-linked=\"Elbit sees IMI making a profit in 2019\" data-tweet=\"$ESLT - Elbit sees IMI making a profit in 2019 https://seekingalpha.com/news/3444035-elbit-sees-imi-making-profit-in-2019?source=tweet\" data-url=\"https://seekingalpha.com/news/3444035-elbit-sees-imi-making-profit-in-2019\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444024\" data-ts=\"1553001620\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLRB\" target=\"_blank\">CLRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444024-cellectar-bio-up-40-premarket-on-advancement-of-clr-131\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellectar Bio up 40% premarket on advancement of CLR 131</a></h4><ul><li>Thinly traded nano cap Cellectar Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a>) is up <font color=\"green\">40% </font>premarket on robust volume on the heels of the FDA's Import Alert <a href=\"https://seekingalpha.com/pr/17448323-fda-grants-exemption-import-alert-cellectar-s-clr-131-pediatric-adolescent-patients\" target=\"_blank\">exemption </a>granted to the Centre for Probe Development and Commercialization &#40;CPDC&#41; related to the company's pediatric IND for lead candidate CLR 131.</li><li>The exemption allows enrollment to begin in a Phase 1 pediatric study in relapsed/refractory solid tumors.</li><li>Enrollment is already underway in Phase 1 &amp; 2 trials in multiple myeloma and certain B-cell lymphomas.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444024\" data-linked=\"Cellectar Bio up 40% premarket on advancement of CLR 131\" data-tweet=\"$CLRB - Cellectar Bio up 40% premarket on advancement of CLR 131 https://seekingalpha.com/news/3444024-cellectar-bio-up-40-premarket-on-advancement-of-clr-131?source=tweet\" data-url=\"https://seekingalpha.com/news/3444024-cellectar-bio-up-40-premarket-on-advancement-of-clr-131\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444022\" data-ts=\"1553001268\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EMES\" target=\"_blank\">EMES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444022-emerge-energy-files-to-delay-10-k-sharesminus-5-after-yesterdays-big-gain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Emerge Energy files to delay 10-K; shares -5% after yesterday&#39;s big gain</a></h4><ul><li>Emerge Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/EMES' title='Emerge Energy Services LP'>EMES</a>) <font color=\"red\">-5.2%</font> pre-market after <a href=\"https://www.sec.gov/Archives/edgar/data/1555177/000110465919015722/a19-6798_1nt10k.htm\" target=\"_blank\">filing to delay</a> its FY 2018 Form 10-K, saying it was unable to file the report without unreasonable effort or expense.</li><li>EMES says it has entered into several forbearance agreements and amendments to credit and note purchase agreement which have required significant amounts of management time that ordinarily would be devoted to preparation of the 10-K.</li><li>EMES shares soared 28% in yesterday's trade despite any apparent news.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444022\" data-linked=\"Emerge Energy files to delay 10-K; shares -5% after yesterday&#39;s big gain\" data-tweet=\"$EMES - Emerge Energy files to delay 10-K; shares -5% after yesterday&#39;s big gain https://seekingalpha.com/news/3444022-emerge-energy-files-to-delay-10-k-sharesminus-5-after-yesterdays-big-gain?source=tweet\" data-url=\"https://seekingalpha.com/news/3444022-emerge-energy-files-to-delay-10-k-sharesminus-5-after-yesterdays-big-gain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444021\" data-ts=\"1553001195\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444021-sdrl-sbgl-and-crbp-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SDRL, SBGL and CRBP among premarket gainers</a></h4><ul><li>Altimmune (NASDAQ:<a href='https://seekingalpha.com/symbol/ALT' title='Altimmune, Inc.'>ALT</a>) <font color=\"green\">+44%</font> on positive NasoVAX <a href=\"https://seekingalpha.com/news/3443971-altimmune-37-percent-premarket-positive-nasovax-data\" target=\"_blank\">data</a>.</li><li>Vaxart (NASDAQ:<a href='https://seekingalpha.com/symbol/VXRT' title='Vaxart, Inc.'>VXRT</a>) <font color=\"green\">+33%</font> on <a href=\"https://seekingalpha.com/news/3443991-vaxart-plus-16-percent-initiating-norovirus-vaccine-phase-1b-clinical-trial\" target=\"_blank\">initiating</a> norovirus vaccine phase 1b clinical trial.</li><li>Cellectar Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a>) <font color=\"green\">+26%</font> as FDA <a href=\"https://seekingalpha.com/pr/17448323-fda-grants-exemption-import-alert-cellectar-s-clr-131-pediatric-adolescent-patients\" target=\"_blank\">grants</a> an exemption to the import alert placed on the centre for probe development and commercialization.</li><li>StoneCo (NASDAQ:<a href='https://seekingalpha.com/symbol/STNE' title='StoneCo Ltd.'>STNE</a>) <font color=\"green\">+20%</font> on <a href=\"https://seekingalpha.com/news/3443780-stoneco-reports-q4-results\" target=\"_blank\">Q4 earnings</a>.</li><li>Aytu BioScience (NASDAQ:<a href='https://seekingalpha.com/symbol/AYTU' title='Aytu BioScience, Inc.'>AYTU</a>) <font color=\"green\">+15%</font> on <a href=\"https://seekingalpha.com/pr/17448259-aytu-bioscience-announces-two-recent-publications-highlighting-improved-efficacy-patient\" target=\"_blank\">announcing</a> two recent publications summarizing findings from the Phase 4, Natesto ''MY-T study.</li><li>Vascular Biogenics (NASDAQ:<a href='https://seekingalpha.com/symbol/VBLT' title='Vascular Biogenics Ltd.'>VBLT</a>) <font color=\"green\">+11%</font> on encouraging VB-111 <a href=\"https://seekingalpha.com/news/3443997-vbl-11-percent-premarket-encouraging-vbminus-111-data\" target=\"_blank\">data</a>.</li><li>Akari Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics, Plc'>AKTX</a>) <font color=\"green\">+9%</font>.</li><li>The9 (NASDAQ:<a href='https://seekingalpha.com/symbol/NCTY' title='The9 Limited'>NCTY</a>) <font color=\"green\">+8%</font>.</li><li>Sibanye Gold (NYSE:<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a>) <font color=\"green\">+8%.</font></li><li>Corbus Pharmaceuticals Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a>) <font color=\"green\">+8%</font> as Oppenheimer <a href=\"https://seekingalpha.com/news/3443893-corbus-plus-6_3-percent-oppenheimer-sees-big-potential-lead-candidate\" target=\"_blank\">sees</a> big potential in lead candidate.</li><li>The Michaels (NASDAQ:<a href='https://seekingalpha.com/symbol/MIK' title='The Michaels Companies, Inc.'>MIK</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/news/3443942-michaels-companies-beats-0_02-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>HEXO (NYSEMKT:<a href='https://seekingalpha.com/symbol/HEXO' title='HEXO Corp.'>HEXO</a>) <font color=\"green\">+6%</font>.</li><li>Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited'>SDRL</a>) <font color=\"green\">+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444021\" data-linked=\"SDRL, SBGL and CRBP among premarket gainers\" data-tweet=\"$ALT $VXRT $CLRB - SDRL, SBGL and CRBP among premarket gainers https://seekingalpha.com/news/3444021-sdrl-sbgl-and-crbp-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3444021-sdrl-sbgl-and-crbp-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444018\" data-ts=\"1553001061\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444018-dsw-and-aqb-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DSW and AQB among premarket losers</a></h4><ul><li>AquaBounty Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AQB' title='AquaBounty Technologies, Inc.'>AQB</a>) <font color=\"red\">-21%</font> on <a href=\"https://seekingalpha.com/news/3443825-aquabounty-11-percent-hours-equity-offering\" target=\"_blank\">equity offering</a>.</li><li>Urovant Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/UROV' title='Urovant Sciences Ltd.'>UROV</a>) <font color=\"red\">-13%</font> after <a href=\"https://seekingalpha.com/news/3443984-urovant-9-percent-premarket-positive-vibregon-data\" target=\"_blank\">announcing</a> topline results from phase 3 EMPOWUR study.</li><li>Dare Bioscience (NASDAQ:<a href='https://seekingalpha.com/symbol/DARE' title='Daré Bioscience, Inc.'>DARE</a>) <font color=\"red\">-12%</font>.</li><li>Selecta Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SELB' title='Selecta Biosciences, Inc.'>SELB</a>) <font color=\"red\">-10%</font>.</li><li>PhaseBio Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PHAS' title='PhaseBio Pharmaceuticals, Inc.'>PHAS</a>) <font color=\"red\">-10%</font>.</li><li>Eventbrite (NYSE:<a href='https://seekingalpha.com/symbol/EB' title='Eventbrite, Inc.'>EB</a>) <font color=\"red\">-7%</font>.</li><li>DSW (NYSE:<a href='https://seekingalpha.com/symbol/DSW' title='DSW Inc.'>DSW</a>) <font color=\"red\">-7%</font> on <a href=\"https://seekingalpha.com/news/3443940-dsw-misses-0_12-revenue-line\" target=\"_blank\">Q4 earnings</a>.</li><li>Leap Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics, Inc.'>LPTX</a>) <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3444018\" data-linked=\"DSW and AQB among premarket losers\" data-tweet=\"$AQB $UROV $DARE - DSW and AQB among premarket losers https://seekingalpha.com/news/3444018-dsw-and-aqb-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3444018-dsw-and-aqb-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444017\" data-ts=\"1553001013\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444017-abbvie-down-1-premarket-on-partial-hold-on-venetoclax\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AbbVie down 1% premarket on partial hold on venetoclax</a></h4><ul><li>AbbVie (NYSE:<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>) slips <font color=\"red\">1%</font> premarket on light volume in response to the FDA's <a href=\"https://seekingalpha.com/pr/17448425-abbvie-provides-update-venclexta-venclyxto-venetoclax-multiple-myeloma-program\" target=\"_blank\">partial clinical hold</a> on all studies of venetoclax (VENCLEXTA/VENCLYXTO) in multiple myeloma. The action, which suspends enrollment but allows treatment to continue for current study participants, was taken after a higher mortality rate was observed in the venetoclax arm compared to the control arm in the Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02755597?cond=Multiple+Myeloma&amp;intr=Venetoclax&amp;lead=abbvie&amp;phase=2&amp;rank=2\" target=\"_blank\">BELLINI</a> study.</li><li>Approved indications for venetoclax are unaffected.</li><li>Related ticker: (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding AG'>OTCQX:RHHBY</a>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3444017\" data-linked=\"AbbVie down 1% premarket on partial hold on venetoclax\" data-tweet=\"$ABBV $RHHBY - AbbVie down 1% premarket on partial hold on venetoclax https://seekingalpha.com/news/3444017-abbvie-down-1-premarket-on-partial-hold-on-venetoclax?source=tweet\" data-url=\"https://seekingalpha.com/news/3444017-abbvie-down-1-premarket-on-partial-hold-on-venetoclax\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444016\" data-ts=\"1553000972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWO\" target=\"_blank\">TWO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444016-two-harbors-prices-capital-raise-shares-down-2_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Two Harbors prices capital raise; shares down 2.3%</a></h4><ul><li>The company <a href=\"https://investor.twoharborsinvestment.com/press-release/general/two-harbors-investment-corp-announces-pricing-public-offering-common-stock\" target=\"_blank\">sold 18M shares </a>for $13.85 each. The underwriters have a greenshoe option to buy another 2.7M shares at that price.</li><li>December 31 book value per share was $13.11. Assuming no sizable rise this year, the deal was done at a premium to book value.</li><li><a href='https://seekingalpha.com/symbol/TWO' title='Two Harbors Investment Corp.'>TWO</a> <font color=\"red\">-2.3%</font> premarket to $13.93.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444016\" data-linked=\"Two Harbors prices capital raise; shares down 2.3%\" data-tweet=\"$TWO - Two Harbors prices capital raise; shares down 2.3% https://seekingalpha.com/news/3444016-two-harbors-prices-capital-raise-shares-down-2_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3444016-two-harbors-prices-capital-raise-shares-down-2_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3444004\" data-ts=\"1553000252\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYNH\" target=\"_blank\">SYNH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3444004-syneos-health-up-10-premarket-on-q4-results-2019-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Syneos Health up 10% premarket on Q4 results/2019 outlook</a></h4><ul><li>Syneos Health (NASDAQ:<a href='https://seekingalpha.com/symbol/SYNH' title='Syneos Health, Inc.'>SYNH</a>) <a href=\"https://seekingalpha.com/pr/17447577-syneos-health-reports-fourth-quarter-full-year-2018-results\" target=\"_blank\">Q4 results</a> ($M): Revenue: 1,145.5 (+6.4%).</li><li>Net income: 45.7 (+404.7%); non-GAAP net income: 99.9 (+34.8%); EPS: 0.44 (+414.3%); non-GAAP EPS: 0.95 (+35.7%); non-GAAP EBITDA: 173.0 (+10.8%).</li><li>Cash flow ops (full year): 303.4 (+53.0%).</li><li><strong>2019 guidance</strong>: Total service revenue: $4,620M - 4,730M; Clinical Solutions revenue: $3,345M - 3,410M; Commercial Solutions revenue: $1,275M - 1,320M; non-GAAP EBITDA: $625M - 660M; non-GAAP EPS: $3.03 - 3.23.</li><li>Consensus view for 2019 is non-GAAP EPS of $3.07 on revenues of $4.68B.</li><li>Shares are up <font color=\"green\">10%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3444004\" data-linked=\"Syneos Health up 10% premarket on Q4 results/2019 outlook\" data-tweet=\"$SYNH - Syneos Health up 10% premarket on Q4 results/2019 outlook https://seekingalpha.com/news/3444004-syneos-health-up-10-premarket-on-q4-results-2019-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3444004-syneos-health-up-10-premarket-on-q4-results-2019-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3443998\" data-ts=\"1552999317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAXN\" target=\"_blank\">AAXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3443998-axon-scores-upgrade-northcoast-aaxnplus-2_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axon scores upgrade at Northcoast; AAXN +2.7%</a></h4><ul><li>Axon (NASDAQ:<a href='https://seekingalpha.com/symbol/AAXN' title='Axon Enterprise, Inc.'>AAXN</a>) is <font color=\"green\">up 2.7%</font> premarket after Northcoast Research <a href=\"https://www.baseballdailydigest.com/news/2019/03/19/axon-enterprise-aaxn-upgraded-by-northcoast-research-to-buy.html\" target=\"_blank\">raised</a> the stock to Buy from Neutral.</li><li>The stock is <font color=\"green\">up 14%</font> since the beginning of the year and <font color=\"green\">37% higher</font> over the last 12 months.</li></ul><div class=\"tiny-share-widget\" data-id=\"3443998\" data-linked=\"Axon scores upgrade at Northcoast; AAXN +2.7%\" data-tweet=\"$AAXN - Axon scores upgrade at Northcoast; AAXN +2.7% https://seekingalpha.com/news/3443998-axon-scores-upgrade-northcoast-aaxnplus-2_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3443998-axon-scores-upgrade-northcoast-aaxnplus-2_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3443997\" data-ts=\"1552999127\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VBLT\" target=\"_blank\">VBLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3443997-vbl-up-11-premarket-on-encouraging-vbminus-111-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VBL up 11% premarket on encouraging VB-111 data</a></h4><ul><li>VBL Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VBLT' title='Vascular Biogenics Ltd.'>VBLT</a>) is up <font color=\"green\">11%</font> premarket on modestly higher volume on the heels of <a href=\"https://seekingalpha.com/pr/17447988-vbl-presents-new-data-potential-vbminus-111-stimulate-immune-system-drive-immune-cells\" target=\"_blank\">new data</a> on anti-cancer gene therapy ofranergene obadenovec (VB-111). The results were presented at the SGO Annual Meeting on Women's Cancer in Honolulu.</li><li>In a mid-stage study, patients with recurrent platinum-resistant ovarian cancer who received the therapeutic dose of VB-111 + paclitaxel experienced prolonged survival &#40;OS&#41; compared to those receiving low-dose VB-111 + paclitaxel. Specifically, median OS was 498 days in the therapeutic dose cohort versus a median of 172 days in the low-dose group.</li><li>Preliminary data from the Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03398655?term=NCT03398655&amp;rank=1\" target=\"_blank\">OVAL </a>study, with a primary endpoint of OS, should be available by year-end.</li></ul><div class=\"tiny-share-widget\" data-id=\"3443997\" data-linked=\"VBL up 11% premarket on encouraging VB-111 data\" data-tweet=\"$VBLT - VBL up 11% premarket on encouraging VB-111 data https://seekingalpha.com/news/3443997-vbl-up-11-premarket-on-encouraging-vbminus-111-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3443997-vbl-up-11-premarket-on-encouraging-vbminus-111-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3443996\" data-ts=\"1552999119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHK\" target=\"_blank\">CHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3443996-chesapeake-energyplus-3-crude-oil-gains-raymond-james-ups-stock-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chesapeake Energy +3% as crude oil gains, Raymond James ups stock target</a></h4><ul><li>Chesapeake Energy (NYSE:<a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a>) <font color=\"green\">+2.8%</font> pre-market as crude oil futures rise and Raymond James analyst James Freeman <a href=\"https://www.marketwatch.com/story/chesapeake-energys-stock-surges-after-bullish-analyst-call-crude-oil-rally-2019-03-19\" target=\"_blank\">raises his price target</a> on the shares to $4.50 from $4 and reiterates his Outperform rating.</li><li>\"While we believe that CHK will modestly outspend cash flow in 2019, we believe that the company has a good chance of being roughly cash flow neutrality in 2020, a very positive step as the firm looks to continue paring down debt,\" Freeman writes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3443996\" data-linked=\"Chesapeake Energy +3% as crude oil gains, Raymond James ups stock target\" data-tweet=\"$CHK - Chesapeake Energy +3% as crude oil gains, Raymond James ups stock target https://seekingalpha.com/news/3443996-chesapeake-energyplus-3-crude-oil-gains-raymond-james-ups-stock-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3443996-chesapeake-energyplus-3-crude-oil-gains-raymond-james-ups-stock-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3443991\" data-ts=\"1552998294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VXRT\" target=\"_blank\">VXRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3443991-vaxartplus-16-on-launch-of-norovirus-vaccine-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vaxart +16% on launch of norovirus vaccine study</a></h4><ul> <li>Vaxart (NASDAQ:<a href='https://seekingalpha.com/symbol/VXRT' title='Vaxart, Inc.'>VXRT</a>) has <a href=\"https://seekingalpha.com/pr/17447936-vaxart-announces-initiation-bivalent-norovirus-vaccine-phase-1b-clinical-trial\" target=\"_blank\">initiated</a> a Phase 1b bivalent       norovirus vaccine clinical trial.</li>          <li>The trial consists of two parts, an       open-label lead-in phase during which 6 subjects will be dosed with       norovirus GII.4 vaccine, and a double-blind phase       during which a total of 80 subjects will be dosed with either placebo, norovirus GI.1 vaccine, norovirus GII.4 vaccine or both norovirus vaccines.</li><li>Both portions of the study are       designed to evaluate safety and immunogenicity. Topline data is expected in H2.</li><li>Shares are up <font color=\"green\">16%</font> premarket.</li>          </ul><div class=\"tiny-share-widget\" data-id=\"3443991\" data-linked=\"Vaxart +16% on launch of norovirus vaccine study\" data-tweet=\"$VXRT - Vaxart +16% on launch of norovirus vaccine study https://seekingalpha.com/news/3443991-vaxartplus-16-on-launch-of-norovirus-vaccine-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3443991-vaxartplus-16-on-launch-of-norovirus-vaccine-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3443988\" data-ts=\"1552998196\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YUM\" target=\"_blank\">YUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3443988-jpmorgan-to-sidelines-on-yum-brands\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan to the sidelines on Yum Brands</a></h4><ul> <li>JPMorgan thinks the recent rally in Yum Brands (NYSE:<a href='https://seekingalpha.com/symbol/YUM' title='YUM! Brands, Inc.'>YUM</a>) has run out of steam.</li> <li>Due to the stretched earnings multiples, JP drops Yum to a Neutral rating from Overweight and keeps a price target of $94 in place. Yum trades at a forward PE ratio of <a href=\"https://seekingalpha.com/symbol/YUM/valuation\" target=\"_blank\">26.27</a> and at 5.67X sales.</li> <li>Shares of Yum are up 9.1% YTD and 21% over the last 52 weeks. In premarket action today, Yum is <font color=\"red\">down 1.44%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3443988\" data-linked=\"JPMorgan to the sidelines on Yum Brands\" data-tweet=\"$YUM - JPMorgan to the sidelines on Yum Brands https://seekingalpha.com/news/3443988-jpmorgan-to-sidelines-on-yum-brands?source=tweet\" data-url=\"https://seekingalpha.com/news/3443988-jpmorgan-to-sidelines-on-yum-brands\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3443987\" data-ts=\"1552997981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HF\" target=\"_blank\">HF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3443987-jones-lang-lasalle-scoops-up-hff-in-2b-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jones Lang LaSalle scoops up HFF in $2B deal</a></h4><ul><li>Terms: HFF (NYSE:<a href='https://seekingalpha.com/symbol/HF' title='HFF, Inc.'>HF</a>) owners will receive $24.63 in cash and 0.1505 JLL (NYSE:<a href='https://seekingalpha.com/symbol/JLL' title='Jones Lang LaSalle Incorporated'>JLL</a>) shares for each share of HF they own.</li><li>Based on yesterday's close for JLL, that would value HFF at $49.16 per share (vs. yesterday's close of $46.51, and $33 at the start of 2019).</li><li>The deal is seen closing in Q3.</li><li>A <a href=\"http://ir.jll.com\" target=\"_blank\">webcast is set</a> for 10 ET.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17448150-b-jll-b-accelerate-growth-capital-markets-business-acquisition-hff\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3443987\" data-linked=\"Jones Lang LaSalle scoops up HFF in $2B deal\" data-tweet=\"$HF $JLL - Jones Lang LaSalle scoops up HFF in $2B deal https://seekingalpha.com/news/3443987-jones-lang-lasalle-scoops-up-hff-in-2b-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3443987-jones-lang-lasalle-scoops-up-hff-in-2b-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3443984\" data-ts=\"1552997846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UROV\" target=\"_blank\">UROV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3443984-urovant-up-9-premarket-on-positive-vibregon-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Urovant up 9% premarket on positive vibregon data</a></h4><ul><li>Thinly traded micro cap Urovant Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/UROV' title='Urovant Sciences Ltd.'>UROV</a>) is up <font color=\"green\">9% </font>premarket on light volume on the heels of a <a href=\"https://seekingalpha.com/pr/17448131-urovant-sciences-announces-positive-topline-results-pivotal-phase-3-empowur-study-vibegron\" target=\"_blank\">positive outcome</a> from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03492281?term=empowur&amp;rank=2\" target=\"_blank\">EMPOWUR</a>, evaluating vibegron in adults with overactive bladder.</li><li>The study met the co-primary endpoints demonstrating that treatment with vibegron produced statistically significant reductions in daily urge incontinence episodes and daily micturitions (urinating) compared to placebo.</li><li>Normally, a successful late-stage study would drive the stock much higher, but investors appear concerned with vibegron's efficacy compared to a cheap generic called tolterodine. The company says vibegron was \"numerically better\" that the generic comparator which means that the separation was not statistically significant, representing a major constraint on vibegron's commercial price, if approved.</li><li>Management will host a conference this morning at 8:30 am ET to discuss the data.</li><li><strong>Update</strong>: Shares are now down <font color=\"red\">10%</font> premarket as the conference is underway.</li></ul><div class=\"tiny-share-widget\" data-id=\"3443984\" data-linked=\"Urovant up 9% premarket on positive vibregon data\" data-tweet=\"$UROV - Urovant up 9% premarket on positive vibregon data https://seekingalpha.com/news/3443984-urovant-up-9-premarket-on-positive-vibregon-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3443984-urovant-up-9-premarket-on-positive-vibregon-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3443982\" data-ts=\"1552997601\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIVE\" target=\"_blank\">FIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3443982-loop-capital-expects-new-highs-for-five-below\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Loop Capital expects new highs for Five Below</a></h4><ul> <li>Loop Capital Markets upgrades Five Below (NASDAQ:<a href='https://seekingalpha.com/symbol/FIVE' title='Five Below, Inc.'>FIVE</a>) to a Buy rating from Hold and takes its price target to $145 (25% upside).</li> <li>The firm points to improved merchandising and execution at Five Below stores, as well as the \"long square footage growth runway\" in place.</li> <li>Shares of Five Below are <font color=\"green\">up 1.30%</font> premarket to $117.88. The 52-week high is $136.13.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3443982\" data-linked=\"Loop Capital expects new highs for Five Below\" data-tweet=\"$FIVE - Loop Capital expects new highs for Five Below https://seekingalpha.com/news/3443982-loop-capital-expects-new-highs-for-five-below?source=tweet\" data-url=\"https://seekingalpha.com/news/3443982-loop-capital-expects-new-highs-for-five-below\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3443971\" data-ts=\"1552996844\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALT\" target=\"_blank\">ALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3443971-altimmune-up-37-premarket-on-positive-nasovax-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altimmune up 37% premarket on positive NasoVAX data</a></h4><ul><li>Nano cap Altimmune (NASDAQ:<a href='https://seekingalpha.com/symbol/ALT' title='Altimmune, Inc.'>ALT</a>) is up <font color=\"green\">37%</font> premarket on robust volume in response to new data from a Phase 2 extension study of intranasal flu vaccine candidate NasoVAX.</li><li>The results showed that 100% of eight evaluated patients remained seroprotected and the seroconversion rate was unchanged more than a year after vaccination. The median hemagglutination inhibition &#40;HAI&#41; titer was more than 3x higher that the level considered effective for immunity.</li><li>The company is seeking development and commercialization partners for the program.</li></ul><div class=\"tiny-share-widget\" data-id=\"3443971\" data-linked=\"Altimmune up 37% premarket on positive NasoVAX data\" data-tweet=\"$ALT - Altimmune up 37% premarket on positive NasoVAX data https://seekingalpha.com/news/3443971-altimmune-up-37-premarket-on-positive-nasovax-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3443971-altimmune-up-37-premarket-on-positive-nasovax-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3443970\" data-ts=\"1552996684\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBIX\" target=\"_blank\">EBIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3443970-ebix-officially-engages-yatra-updates-ebixcash-operations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ebix officially engages Yatra, updates EbixCash operations</a></h4><ul><li>Ebix (NASDAQ:<a href='https://seekingalpha.com/symbol/EBIX' title='Ebix, Inc.'>EBIX</a>) <a href=\"https://seekingalpha.com/pr/17448017-riding-strong-sales-momentum-proven-acquisition-strategy-ebixcash-india-operations-target-600\" target=\"_blank\">reiterates</a> its intent to acquire Yatra Online (NASDAQ:<a href='https://seekingalpha.com/symbol/YTRA' title='Yatra Online, Inc.'>YTRA</a>) and announces the companies have officially engaged to commence due diligence. Ebix wants to complete the acquisition by May 15 and would then merge Yatra into its Indian EbixCash subsidiary.</li><li>The EbixCash operation on a standalone basis is targeting quarterly annualized revenue of $600M and operating income of $180M+ by Q4.</li><li>Yatra shares are <font color=\"green\">up 3.5% </font>pre-market to $5.36. Ebix shares are <font color=\"green\">up 0.4%</font> to $51.82.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441511-yatra-plus-38-percent-ebix-buyout-offer\" target=\"_blank\">Yatra +38% on Ebix buyout offer</a> (March 11)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3443213-yatra-enters-due-diligence-ebix-ytra-plus-4-percent\" target=\"_blank\">Yatra enters due diligence with Ebix; YTRA +4%</a> (March 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3443970\" data-linked=\"Ebix officially engages Yatra, updates EbixCash operations\" data-tweet=\"$EBIX $EBIX $YTRA - Ebix officially engages Yatra, updates EbixCash operations https://seekingalpha.com/news/3443970-ebix-officially-engages-yatra-updates-ebixcash-operations?source=tweet\" data-url=\"https://seekingalpha.com/news/3443970-ebix-officially-engages-yatra-updates-ebixcash-operations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>165&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3443967\" data-ts=\"1552996576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DPZ\" target=\"_blank\">DPZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3443967-dominos-pizza-rises-after-jpmorgan-lift\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Domino&#39;s Pizza rises after JPMorgan lift</a></h4><ul> <li>Shares of Domino's Pizza (NYSE:<a href='https://seekingalpha.com/symbol/DPZ' title='Domino&#39;s Pizza, Inc.'>DPZ</a>) break higher after JPMorgan upgrades the restaurant stock to an Overweight rating from Neutral.</li> <li>\"We agree with company guidance that DPZ is an 8-12% system-wide sales growth company driven by 6-8% unit growth, 3-6% US comps, and 3-6% international comps,\" advises the JP analyst team.</li> <li>The firm's price target of <a href=\"https://www.cnbc.com/2019/03/19/calls-of-the-day-dominos-pizza-yum-brands-booking-holdings--more.html\" target=\"_blank\">$270</a> is 25X the estimate for FY20 EPS.</li> <li>DPZ <font color=\"green\">+1.27%</font> premarket to $246.50 vs. a 52-week trading range of $225.25 to $305.34.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3443967\" data-linked=\"Domino&#39;s Pizza rises after JPMorgan lift\" data-tweet=\"$DPZ - Domino&#39;s Pizza rises after JPMorgan lift https://seekingalpha.com/news/3443967-dominos-pizza-rises-after-jpmorgan-lift?source=tweet\" data-url=\"https://seekingalpha.com/news/3443967-dominos-pizza-rises-after-jpmorgan-lift\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}